{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:46:01Z","timestamp":1792169161889,"version":"4.4.0"},"reference-count":318,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["202604841398"],"award-info":[{"award-number":["202604841398"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Natural Science Foundation","award":["7262174"],"award-info":[{"award-number":["7262174"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"DOI":"10.1186\/s40164-026-00840-x","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:01:56Z","timestamp":1792155716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intratumoral microbiota in cancer immunotherapy: metabolic-epigenetic crosstalk and engineered bacterial therapeutics"],"prefix":"10.1186","volume":"15","author":[{"given":"Niying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4292-0302","authenticated-orcid":false,"given":"Shuye","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"840_CR1","doi-asserted-by":"crossref","first-page":"e2200470","DOI":"10.1002\/advs.202200470","volume":"9","author":"Y Xie","year":"2022","unstructured":"Xie Y, Xie F, Zhou X, Zhang L, Yang B, Huang J, Wang F, Yan H, Zeng L, Zhang L, Zhou F. Microbiota in Tumors: From Understanding to Application. Adv Sci (Weinh). 2022;9:e2200470.","journal-title":"Adv Sci (Weinh)"},{"key":"840_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12929-025-01117-x","volume":"32","author":"N Wang","year":"2025","unstructured":"Wang N, Wu S, Huang L, Hu Y, He X, He J, Hu B, Xu Y, Rong Y, Yuan C, et al. Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer. J Biomed Sci. 2025;32:23.","journal-title":"J Biomed Sci"},{"key":"840_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-024-00543-1","volume":"13","author":"S Zheng","year":"2024","unstructured":"Zheng S, Wang W, Shen L, Yao Y, Xia W, Ni C. Tumor battlefield within inflamed, excluded or desert immune phenotypes: the mechanisms and strategies. Exp Hematol Oncol. 2024;13:80.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR4","doi-asserted-by":"crossref","first-page":"1409464","DOI":"10.3389\/fcimb.2024.1409464","volume":"14","author":"W Liu","year":"2024","unstructured":"Liu W, Li Y, Wu P, Guo X, Xu Y, Jin L, Zhao D. The intratumoral microbiota: a new horizon in cancer immunology. Front Cell Infect Microbiol. 2024;14:1409464.","journal-title":"Front Cell Infect Microbiol"},{"key":"840_CR5","doi-asserted-by":"crossref","first-page":"1526589","DOI":"10.3389\/fimmu.2025.1526589","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Duan X, Zhao Y, Zhang D, Zhang Y. Implications of intratumoral microbiota in tumor metastasis: a special perspective of microorganisms in tumorigenesis and clinical therapeutics. Front Immunol. 2025;16:1526589.","journal-title":"Front Immunol"},{"key":"840_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S002217240003309X","volume":"7","author":"LS Dudgeon","year":"1907","unstructured":"Dudgeon LS, Dunkley EV. The Micrococcus neoformans: Its Cultural Characters and Pathogenicity and the Results of the Estimation of the Opsonic and Agglutinative Properties of the Serum of Patients Suffering from Malignant Disease on this Organism and on the Staphylococcus Albus. J Hyg (Lond). 1907;7:13\u201321.","journal-title":"J Hyg (Lond)"},{"key":"840_CR7","first-page":"1273","volume":"1","author":"JR Warren","year":"1983","unstructured":"Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273\u20135.","journal-title":"Lancet"},{"key":"840_CR8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175\u20136.","journal-title":"Lancet"},{"key":"840_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s43556-025-00248-9","volume":"6","author":"S Zhang","year":"2025","unstructured":"Zhang S, Huang J, Jiang Z, Tong H, Ma X, Liu Y. Tumor microbiome: roles in tumor initiation, progression, and therapy. Mol Biomed. 2025;6:9.","journal-title":"Mol Biomed"},{"key":"840_CR10","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1038\/s44319-025-00482-w","volume":"26","author":"G Vella","year":"2025","unstructured":"Vella G, Rescigno M. Cancer microbiota: a focus on tumor-resident bacteria. EMBO Rep. 2025;26:2977\u201393.","journal-title":"EMBO Rep"},{"key":"840_CR11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, Gavert N, Zwang Y, Geller LT, Rotter-Maskowitz A, Weiser R, Mallel G, Gigi E, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"840_CR12","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","volume":"185","author":"AB Dohlman","year":"2022","unstructured":"Dohlman AB, Klug J, Mesko M, Gao IH, Lipkin SM, Shen X, Iliev ID. A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors. Cell. 2022;185:3807\u2013e38223812.","journal-title":"Cell"},{"key":"840_CR13","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.cell.2022.09.005","volume":"185","author":"L Narunsky-Haziza","year":"2022","unstructured":"Narunsky-Haziza L, Sepich-Poore GD, Livyatan I, Asraf O, Martino C, Nejman D, Gavert N, Stajich JE, Amit G, Gonz\u00e1lez A, et al. Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions. Cell. 2022;185:3789\u2013e38063717.","journal-title":"Cell"},{"key":"840_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s43018-025-00932-3","volume":"6","author":"L Qiao","year":"2025","unstructured":"Qiao L, Niu L, Wang Z, Deng Z, Di D, Ma X, Zhou Y, Kong D, Wang Q, Yin J, et al. Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nat Cancer. 2025;6:612\u201328.","journal-title":"Nat Cancer"},{"key":"840_CR15","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, Pei S, Lu W, Li Y, Huang JD, Xiao Y, Liu C. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188:1842\u2013e18571820.","journal-title":"Cell"},{"key":"840_CR16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.chom.2025.04.003","volume":"33","author":"J Yu","year":"2025","unstructured":"Yu J, Liang Y, Zhang Q, Ding H, Xie M, Zhang J, Hu W, Xu S, Xiao Y, Xu S, et al. An interplay between human genetics and intratumoral microbiota in the progression of colorectal cancer. Cell Host Microbe. 2025;33:657\u2013e670656.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"840_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ccell.2025.09.010","volume":"44","author":"JL Galeano Nino","year":"2026","unstructured":"Galeano Nino JL, Ponath F, Ajisafe VA, Becker CR, Kempchinsky AG, Zepeda-Rivera MA, Gomez JA, Wu H, Terrazas JG, Bouzek H, et al. Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest. Cancer Cell. 2026;44(1):166\u2013e18616.","journal-title":"Cancer Cell"},{"key":"840_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fonc.2020.00179","volume":"10","author":"SP Walker","year":"2020","unstructured":"Walker SP, Tangney M, Claesson MJ. Sequence-Based Characterization of Intratumoral Bacteria-A Guide to Best Practice. Front Oncol. 2020;10:179.","journal-title":"Front Oncol"},{"issue":"15","key":"840_CR19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/cells13151279","volume":"13","author":"AA Kyriazi","year":"2024","unstructured":"Kyriazi AA, Karaglani M, Agelaki S, Baritaki S. Intratumoral Microbiome: Foe or Friend in Reshaping the Tumor Microenvironment Landscape? Cells. 2024;13(15):1279.","journal-title":"Cells"},{"key":"840_CR20","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1007\/s10620-025-09157-x","volume":"70","author":"W Chen","year":"2025","unstructured":"Chen W, Zhang X, Chi M, Zheng Q. Intratumoral Microbe Correlated with Expression of DNA Methylation Genes in Hepatocellular Carcinoma. Dig Dis Sci. 2025;70:3383\u201393.","journal-title":"Dig Dis Sci"},{"key":"840_CR21","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.4251\/wjgo.v16.i10.4232","volume":"16","author":"BQ Liu","year":"2024","unstructured":"Liu BQ, Bai Y, Chen DP, Zhang YM, Wang TZ, Chen JR, Liu XY, Zheng B, Cui ZL. Intratumoural microorganism can affect the progression of hepatocellular carcinoma. World J Gastrointest Oncol. 2024;16:4232\u201343.","journal-title":"World J Gastrointest Oncol"},{"key":"840_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.chom.2026.01.020","volume":"34","author":"X Ren","year":"2026","unstructured":"Ren X, Zheng G, Liu Y, Li S, Liu S, Wen Y, Zhang Y, Zhao Y, Guan H, Wang X, et al. Intratumoral bacterium Enterocloster bolteae promotes hepatocellular carcinoma progression by directly binding tumor cells. Cell Host Microbe. 2026;34:406\u2013e424410.","journal-title":"Cell Host Microbe"},{"key":"840_CR23","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/nm.2015","volume":"15","author":"S Wu","year":"2009","unstructured":"Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15:1016\u201322.","journal-title":"Nat Med"},{"key":"840_CR24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1127059","volume":"313","author":"JP Nougayr\u00e8de","year":"2006","unstructured":"Nougayr\u00e8de JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313:848\u201351.","journal-title":"Science"},{"key":"840_CR25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.aah3648","volume":"359","author":"CM Dejea","year":"2018","unstructured":"Dejea CM, Fathi P, Craig JM, Boleij A, Taddese R, Geis AL, Wu X, DeStefano Shields CE, Hechenbleikner EM, Huso DL, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359:592\u20137.","journal-title":"Science"},{"key":"840_CR26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, Qian Y, Kryczek I, Sun D, Nagarsheth N, et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017;170:548\u2013e563516.","journal-title":"Cell"},{"issue":"19","key":"840_CR27","doi-asserted-by":"crossref","first-page":"9710","DOI":"10.3390\/ijms26199710","volume":"26","author":"D Incognito","year":"2025","unstructured":"Incognito D, Ciappina G, Gelsomino C, Picone A, Consolo P, Scano A, Franchina T, Maurea N, Quagliariello V, Berretta S, et al. Fusobacterium Nucleatum in Colorectal Cancer: Relationship Among Immune Modulation, Potential Biomarkers and Therapeutic Implications. Int J Mol Sci. 2025;26(19):9710.","journal-title":"Int J Mol Sci"},{"key":"840_CR28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.7150\/thno.38870","volume":"10","author":"Y Chen","year":"2020","unstructured":"Chen Y, Chen Y, Zhang J, Cao P, Su W, Deng Y, Zhan N, Fu X, Huang Y, Dong W. Fusobacterium nucleatum Promotes Metastasis in Colorectal Cancer by Activating Autophagy Signaling via the Upregulation of CARD3 Expression. Theranostics. 2020;10:323\u201339.","journal-title":"Theranostics"},{"key":"840_CR29","doi-asserted-by":"crossref","first-page":"114512","DOI":"10.1016\/j.jconrel.2025.114512","volume":"390","author":"Y Yu","year":"2026","unstructured":"Yu Y, Jin Y, Zhou Y, Cui Z, Xin Y, Liu H, Zhao J, Elsabahy M, Su M, Gao H. Nanoprodrug targeting tumor-associated intracellular bacteria enhances colorectal cancer immunotherapy. J Control Release. 2026;390:114512.","journal-title":"J Control Release"},{"key":"840_CR30","doi-asserted-by":"crossref","first-page":"2442037","DOI":"10.1080\/19490976.2024.2442037","volume":"17","author":"F Chen","year":"2025","unstructured":"Chen F, Guo S, Li Y, Lu Y, Liu L, Chen S, An J, Zhang G. Fusobacterium nucleatum-driven CX3CR1(+) PD-L1(+) phagocytes route to tumor tissues and reshape tumor microenvironment. Gut Microbes. 2025;17:2442037.","journal-title":"Gut Microbes"},{"key":"840_CR31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ccell.2025.09.010","volume":"44","author":"JL Galeano Ni\u00f1o","year":"2026","unstructured":"Galeano Ni\u00f1o JL, Ponath F, Ajisafe VA, Becker CR, Kempchinsky AG, Zepeda-Rivera MA, Gomez JA, Wu H, Terrazas JG, Bouzek H, et al. Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest. Cancer Cell. 2026;44:166\u2013e186116.","journal-title":"Cancer Cell"},{"key":"840_CR32","doi-asserted-by":"crossref","first-page":"2265138","DOI":"10.1080\/19490976.2023.2265138","volume":"15","author":"E Bergsten","year":"2023","unstructured":"Bergsten E, Mestivier D, Donnadieu F, Pedron T, Barau C, Meda LT, Mettouchi A, Lemichez E, Gorgette O, Chamaillard M, et al. Parvimonas micra, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes. Gut Microbes. 2023;15:2265138.","journal-title":"Gut Microbes"},{"key":"840_CR33","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1038\/s41388-022-02395-7","volume":"41","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhang X, Zhou Y, Fu K, Lau HC, Chun TW, Cheung AH, Coker OO, Wei H, Wu WK, et al. Parvimonas micra promotes colorectal tumorigenesis and is associated with prognosis of colorectal cancer patients. Oncogene. 2022;41:4200\u201310.","journal-title":"Oncogene"},{"key":"840_CR34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/19768354.2024.2442401","volume":"29","author":"DK Nguyen","year":"2025","unstructured":"Nguyen DK, Kang MJ, Oh SJ, Park HJ, Kim SH, Yu JH, Lee Y, Lee HS, Yang JW, Seo Y, et al. Parvimonas micra-polarized M2-like tumor-associated macrophages accelerate colorectal cancer development via IL-8 secretion. Anim Cells Syst (Seoul). 2025;29:24\u201334.","journal-title":"Anim Cells Syst (Seoul)"},{"key":"840_CR35","doi-asserted-by":"crossref","unstructured":"Chang Y, Yang C, Hou F, Zhu Y, Huang Z, Wang L, Liu Y, Zhang H, Qin X, Hao Z et al. Parvimonas micra-derived SirTM: An ADP-ribosyltransferase as a novel driver in colorectal cancer progression. J Adv Res 2026.","DOI":"10.1016\/j.jare.2026.03.035"},{"key":"840_CR36","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y, Li H, Bai H, Liu X, Zhang Y, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185:1356\u2013e13721326.","journal-title":"Cell"},{"issue":"18","key":"840_CR37","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.3390\/cancers17182947","volume":"17","author":"SK Rad","year":"2025","unstructured":"Rad SK, Li R, Yeo KKL, Cooksley C, Shaghayegh G, Vreugde S, Wu F, Tomita Y, Price TJ, Ingman WV, et al. Cell Line-Dependent Internalization, Persistence, and Immunomodulatory Effects of Staphylococcus aureus in Triple-Negative Breast Cancer. Cancers (Basel). 2025;17(18):2947.","journal-title":"Cancers (Basel)"},{"key":"840_CR38","doi-asserted-by":"crossref","first-page":"e0341069","DOI":"10.1371\/journal.pone.0341069","volume":"21","author":"L Ye","year":"2026","unstructured":"Ye L, Yu G, Cheng Y, Fan L. DnaK supports intracellular persistence of Staphylococcus xylosus and confers mechanical resilience to a human breast cancer cell line. PLoS ONE. 2026;21:e0341069.","journal-title":"PLoS ONE"},{"issue":"1","key":"840_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13058-026-02297-6","volume":"28","author":"C Cheng","year":"2026","unstructured":"Cheng C, Yuan F, Li J, Fan Y, Liu Y, Zhang Q, Lu Y, He L. High-fat diet reshapes microbial interactions to promote breast cancer stemness via Streptococcus mutans-induced leucine accumulation. Breast Cancer Res. 2026;28(1):124.","journal-title":"Breast Cancer Res"},{"key":"840_CR40","doi-asserted-by":"crossref","first-page":"123848","DOI":"10.1016\/j.biomaterials.2025.123848","volume":"328","author":"Z Liu","year":"2026","unstructured":"Liu Z, Guan Q, Xin J, Tang W, Chen Y, Zhang J, Chen J, Bi S, Wang P, Liu J. Chemo-immunotherapeutic potential of Lactobacillus rhamnosus GG and its bioengineering for cancer therapy. Biomaterials. 2026;328:123848.","journal-title":"Biomaterials"},{"key":"840_CR41","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41598-024-51361-8","volume":"14","author":"CC Liu","year":"2024","unstructured":"Liu CC, Wolf M, Ortego R, Grencewicz D, Sadler T, Eng C. Characterization of immunomodulating agents from Staphylococcus aureus for priming immunotherapy in triple-negative breast cancers. Sci Rep. 2024;14:756.","journal-title":"Sci Rep"},{"key":"840_CR42","doi-asserted-by":"crossref","first-page":"1176044","DOI":"10.3389\/fimmu.2023.1176044","volume":"14","author":"E Goeteyn","year":"2023","unstructured":"Goeteyn E, Grassi L, Van den Bossche S, Rigauts C, Vande Weygaerde Y, Van Braeckel E, Maes T, Bracke KR, Crabb\u00e9 A. Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model. Front Immunol. 2023;14:1176044.","journal-title":"Front Immunol"},{"key":"840_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41389-024-00513-6","volume":"13","author":"JK Stone","year":"2024","unstructured":"Stone JK, von Muhlinen N, Zhang C, Robles AI, Flis AL, Vega-Valle E, Miyanaga A, Matsumoto M, Greathouse KL, Cooks T, et al. Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development. Oncogenesis. 2024;13:13.","journal-title":"Oncogenesis"},{"key":"840_CR44","doi-asserted-by":"crossref","first-page":"2548626","DOI":"10.1080\/21505594.2025.2548626","volume":"16","author":"G Sha","year":"2025","unstructured":"Sha G, Wu Z, Wang B, Ding Y, Xiao Z, Zhang W, Zhou J, Zhou Y, Ji G, Tian Z, et al. Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression. Virulence. 2025;16:2548626.","journal-title":"Virulence"},{"key":"840_CR45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13027-025-00689-5","volume":"20","author":"X Song","year":"2025","unstructured":"Song X, Wang J, Gu Z, Qiu X, Yuan M, Ke H, Deng R. Porphyromonas gingivalis and Fusobacterium nucleatum synergistically strengthen the effect of promoting oral squamous cell carcinoma progression. Infect Agent Cancer. 2025;20:60.","journal-title":"Infect Agent Cancer"},{"key":"840_CR46","first-page":"OF1","volume":"16","author":"Tumor-infiltrating Bacteria","year":"2026","unstructured":"Tumor-infiltrating Bacteria. Induce Quiescence and Therapy Resistance. Cancer Discov. 2026;16:OF1.","journal-title":"Cancer Discov"},{"key":"840_CR47","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1158\/0008-5472.CAN-24-2580","volume":"85","author":"T Zhang","year":"2025","unstructured":"Zhang T, Li Y, Zhai E, Zhao R, Qian Y, Huang Z, Liu Y, Zhao Z, Xu X, Liu J, et al. Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion. Cancer Res. 2025;85:1819\u201341.","journal-title":"Cancer Res"},{"key":"840_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41421-024-00746-0","volume":"10","author":"L Yuan","year":"2024","unstructured":"Yuan L, Pan L, Wang Y, Zhao J, Fang L, Zhou Y, Xia R, Ma Y, Jiang Z, Xu Z, et al. Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression. Cell Discov. 2024;10:117.","journal-title":"Cell Discov"},{"key":"840_CR49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41392-022-01159-9","volume":"7","author":"C Xue","year":"2022","unstructured":"Xue C, Jia J, Gu X, Zhou L, Lu J, Zheng Q, Su Y, Zheng S, Li L. Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma. Signal Transduct Target Ther. 2022;7:335.","journal-title":"Signal Transduct Target Ther"},{"key":"840_CR50","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1053\/j.gastro.2021.02.020","volume":"160","author":"W Liu","year":"2021","unstructured":"Liu W, Zhang X, Xu H, Li S, Lau HC, Chen Q, Zhang B, Zhao L, Chen H, Sung JJ, Yu J. Microbial Community Heterogeneity Within Colorectal Neoplasia and its Correlation With Colorectal Carcinogenesis. Gastroenterology. 2021;160:2395\u2013408.","journal-title":"Gastroenterology"},{"key":"840_CR51","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358:1443\u20138.","journal-title":"Science"},{"key":"840_CR52","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1099\/jmm.0.46918-0","volume":"56","author":"SJ Hooper","year":"2007","unstructured":"Hooper SJ, Crean SJ, Fardy MJ, Lewis MAO, Spratt DA, Wade WG, Wilson MJ. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol. 2007;56:1651\u20139.","journal-title":"J Med Microbiol"},{"key":"840_CR53","doi-asserted-by":"crossref","first-page":"1614731","DOI":"10.3389\/fimmu.2025.1614731","volume":"16","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Yang Z, Wu D, Zhao H. Dissecting the intratumoral microbiome landscape in lung cancer. Front Immunol. 2025;16:1614731.","journal-title":"Front Immunol"},{"key":"840_CR54","doi-asserted-by":"crossref","first-page":"1704491","DOI":"10.3389\/fmicb.2025.1704491","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Zhang Y, Zhang G, Wang D, Dou L, Wang Y, Huang Z, Liu X. Spatial microbiome-metabolic crosstalk drives CD8(+) T-cell exhaustion through the butyrate-HDAC axis in colorectal cancer. Front Microbiol. 2025;16:1704491.","journal-title":"Front Microbiol"},{"key":"840_CR55","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, Gandini S, Lizier M, Braga D, Asnicar F, et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 2021;39:708\u2013e724711.","journal-title":"Cancer Cell"},{"issue":"5","key":"840_CR56","doi-asserted-by":"crossref","first-page":"e20192282","DOI":"10.1084\/jem.20192282","volume":"217","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng W, Yang K, Harris KG, Ni K, Xue L, Lin W, Chang EB, Weichselbaum RR, Fu YX. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med. 2020;217(5):e20192282.","journal-title":"J Exp Med"},{"key":"840_CR57","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-025-02335-3","volume":"11","author":"Y Yao","year":"2026","unstructured":"Yao Y, Zhu Y, Chen K, Chen J, Li Y, Li D, Wei P. Microbiota in cancer: current understandings and future perspectives. Signal Transduct Target Ther. 2026;11:39.","journal-title":"Signal Transduct Target Ther"},{"key":"840_CR58","doi-asserted-by":"crossref","first-page":"e0098322","DOI":"10.1128\/spectrum.00983-22","volume":"10","author":"JH Huang","year":"2022","unstructured":"Huang JH, Wang J, Chai XQ, Li ZC, Jiang YH, Li J, Liu X, Fan J, Cai JB, Liu F. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma. Microbiol Spectr. 2022;10:e0098322.","journal-title":"Microbiol Spectr"},{"key":"840_CR59","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1126\/science.aal5240","volume":"358","author":"S Bullman","year":"2017","unstructured":"Bullman S, Pedamallu CS, Sicinska E, Clancy TE, Zhang X, Cai D, Neuberg D, Huang K, Guevara F, Nelson T, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science. 2017;358:1443\u20138.","journal-title":"Science"},{"key":"840_CR60","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ccell.2021.03.004","volume":"39","author":"A Bertocchi","year":"2021","unstructured":"Bertocchi A, Carloni S, Ravenda PS, Bertalot G, Spadoni I, Lo Cascio A, Gandini S, Lizier M, Braga D, Asnicar F, et al. Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver. Cancer Cell. 2021;39:708\u2013e724711.","journal-title":"Cancer Cell"},{"key":"840_CR61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.21147\/j.issn.1000-9604.2024.06.07","volume":"36","author":"Z Zong","year":"2024","unstructured":"Zong Z, Zeng W, Li Y, Wang M, Cao Y, Cheng X, Jin Z, Mao S, Zhu X. Intratumor microbiota and colorectal cancer: Comprehensive and lucid review. Chin J Cancer Res. 2024;36:683\u201399.","journal-title":"Chin J Cancer Res"},{"key":"840_CR62","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4103\/jcrt.jcrt_38_24","volume":"21","author":"T Wang","year":"2025","unstructured":"Wang T, Lin S, Ji Y, Puqiong C, Gao J, Li S. Prognostic impact of Fusobacterium nucleatum on survival in colorectal cancer: A systematic review and meta-analysis. J Cancer Res Ther. 2025;21:796\u2013803.","journal-title":"J Cancer Res Ther"},{"key":"840_CR63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/MS9.0000000000004253","volume":"88","author":"MS Mehmood","year":"2026","unstructured":"Mehmood MS, Qasim Z, Rauf S, Danaf N. Intratumoral Fusobacterium nucleatum metabolizes chemotherapy before it reaches cancer cells. Ann Med Surg (Lond). 2026;88:939\u201340.","journal-title":"Ann Med Surg (Lond)"},{"key":"840_CR64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ccell.2025.09.010","volume":"44","author":"JL Galeano Nino","year":"2026","unstructured":"Galeano Nino JL, Ponath F, Ajisafe VA, Becker CR, Kempchinsky AG, Zepeda-Rivera MA, Gomez JA, Wu H, Terrazas JG, Bouzek H, et al. Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest. Cancer Cell. 2026;44:166\u2013e186116.","journal-title":"Cancer Cell"},{"key":"840_CR65","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00262-018-2233-x","volume":"67","author":"T Chen","year":"2018","unstructured":"Chen T, Li Q, Wu J, Wu Y, Peng W, Li H, Wang J, Tang X, Peng Y, Fu X. Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism. Cancer Immunol Immunother. 2018;67:1635\u201346.","journal-title":"Cancer Immunol Immunother"},{"key":"840_CR66","doi-asserted-by":"crossref","first-page":"658681","DOI":"10.3389\/fimmu.2021.658681","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu L, Liu Y, Kong X, Wu R, Peng Q, Zhang Y, Zhou L, Duan L. Fusobacterium nucleatum Facilitates M2 Macrophage Polarization and Colorectal Carcinoma Progression by Activating TLR4\/NF-kappaB\/S100A9 Cascade. Front Immunol. 2021;12:658681.","journal-title":"Front Immunol"},{"key":"840_CR67","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2020-322780","volume":"70","author":"J Hong","year":"2021","unstructured":"Hong J, Guo F, Lu SY, Shen C, Ma D, Zhang X, Xie Y, Yan T, Yu T, Sun T, et al. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut. 2021;70:2123\u201337.","journal-title":"Gut"},{"key":"840_CR68","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/gast.2003.50047","volume":"124","author":"S Wu","year":"2003","unstructured":"Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology. 2003;124:392\u2013400.","journal-title":"Gastroenterology"},{"issue":"6","key":"840_CR69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/toxins17060305","volume":"17","author":"S Jasemi","year":"2025","unstructured":"Jasemi S, Molicotti P, Fais M, Cossu I, Simula ER, Sechi LA. Biological Mechanisms of Enterotoxigenic Bacteroides fragilis Toxin: Linking Inflammation, Colorectal Cancer, and Clinical Implications. Toxins (Basel). 2025;17(6):305.","journal-title":"Toxins (Basel)"},{"key":"840_CR70","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/MS9.0000000000004287","volume":"88","author":"MS Mehmood","year":"2026","unstructured":"Mehmood MS, Danaf N. Bacteroides fragilis toxin in colorectal tumors activates STAT3 and drives microsatellite instability. Ann Med Surg (Lond). 2026;88:957\u20138.","journal-title":"Ann Med Surg (Lond)"},{"key":"840_CR71","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1127059","volume":"313","author":"JP Nougayrede","year":"2006","unstructured":"Nougayrede JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313:848\u201351.","journal-title":"Science"},{"issue":"6","key":"840_CR72","doi-asserted-by":"crossref","first-page":"BSR20230609","DOI":"10.1042\/BSR20230609","volume":"43","author":"MNA Hatta","year":"2023","unstructured":"Hatta MNA, Mohamad Hanif EA, Chin SF, Low TY, Neoh HM. Parvimonas micra infection enhances proliferation, wound healing, and inflammation of a colorectal cancer cell line. Biosci Rep. 2023;43(6):BSR20230609.","journal-title":"Biosci Rep"},{"key":"840_CR73","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41564-024-01695-w","volume":"9","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wong CC, Ding Y, Gao M, Wen J, Lau HC, Cheung AH, Huang D, Huang H, Yu J. Peptostreptococcus anaerobius mediates anti-PD1 therapy resistance and exacerbates colorectal cancer via myeloid-derived suppressor cells in mice. Nat Microbiol. 2024;9:1467\u201382.","journal-title":"Nat Microbiol"},{"key":"840_CR74","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Nino","year":"2022","unstructured":"Galeano Nino JL, Wu H, LaCourse KD, Kempchinsky AG, Baryiames A, Barber B, Futran N, Houlton J, Sather C, Sicinska E, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810\u20137.","journal-title":"Nature"},{"key":"840_CR75","doi-asserted-by":"publisher","first-page":"30751","DOI":"10.1038\/srep30751","volume":"6","author":"TJ Hieken","year":"2016","unstructured":"Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, et al. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. Sci Rep. 2016;6:30751.","journal-title":"Sci Rep"},{"key":"840_CR76","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","volume":"185","author":"A Fu","year":"2022","unstructured":"Fu A, Yao B, Dong T, Chen Y, Yao J, Liu Y, Li H, Bai H, Liu X, Zhang Y, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185:1356\u2013e13721326.","journal-title":"Cell"},{"key":"840_CR77","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/01635581.2012.700758","volume":"64","author":"J Escamilla","year":"2012","unstructured":"Escamilla J, Lane MA, Maitin V. Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer. 2012;64:871\u20138.","journal-title":"Nutr Cancer"},{"key":"840_CR78","doi-asserted-by":"crossref","first-page":"e13439","DOI":"10.1111\/asj.13439","volume":"91","author":"B Wang","year":"2020","unstructured":"Wang B, Wu Y, Liu R, Xu H, Mei X, Shang Q, Liu S, Yu D, Li W. Lactobacillus rhamnosus GG promotes M1 polarization in murine bone marrow-derived macrophages by activating TLR2\/MyD88\/MAPK signaling pathway. Anim Sci J. 2020;91:e13439.","journal-title":"Anim Sci J"},{"key":"840_CR79","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.biopha.2016.07.001","volume":"83","author":"Y Gamallat","year":"2016","unstructured":"Gamallat Y, Meyiah A, Kuugbee ED, Hago AM, Chiwala G, Awadasseid A, Bamba D, Zhang X, Shang X, Luo F, Xin Y. Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed Pharmacother. 2016;83:536\u201341.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"840_CR80","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41419-026-08494-7","volume":"17","author":"C Yang","year":"2026","unstructured":"Yang C, Yang R, Zheng B, Jiang H, Wang X, Huang W. Lactylation as a metabolic-epigenetic switch in cancer: dual roles in cell death resistance and therapeutic vulnerability. Cell Death Dis. 2026;17(1):298.","journal-title":"Cell Death Dis"},{"issue":"9","key":"840_CR81","doi-asserted-by":"crossref","first-page":"lxaf230","DOI":"10.1093\/jambio\/lxaf230","volume":"136","author":"L Jiang","year":"2025","unstructured":"Jiang L, Li M, Zhao Z. Intra-tumoral microbial heterogeneity of breast cancer: roles in tumorigenesis, therapeutic responses, and future directions. J Appl Microbiol. 2025;136(9):lxaf230.","journal-title":"J Appl Microbiol"},{"key":"840_CR82","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13059-016-1021-1","volume":"17","author":"G Yu","year":"2016","unstructured":"Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC, Caporaso NE, Goedert JJ, Ravel J, Landi MT. Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol. 2016;17:163.","journal-title":"Genome Biol"},{"key":"840_CR83","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s12866-023-02882-1","volume":"23","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Zeng H, Liu K, Pan H, Wang B, Zhu M, Wang J, Wang H, Chen H, Shen D, et al. Microbiota profiles in the saliva, cancerous tissues and its companion paracancerous tissues among Chinese patients with lung cancer. BMC Microbiol. 2023;23:237.","journal-title":"BMC Microbiol"},{"key":"840_CR84","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"41","author":"LE Colbert","year":"2023","unstructured":"Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41:1945\u201362. e1911.","journal-title":"Cancer Cell"},{"issue":"5","key":"840_CR85","doi-asserted-by":"crossref","first-page":"2101293","DOI":"10.1183\/13993003.01293-2021","volume":"59","author":"C Rigauts","year":"2022","unstructured":"Rigauts C, Aizawa J, Taylor SL, Rogers GB, Govaerts M, Cos P, Ostyn L, Sims S, Vandeplassche E, Sze M, et al. Rothia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. Eur Respir J. 2022;59(5):2101293.","journal-title":"Eur Respir J"},{"key":"840_CR86","doi-asserted-by":"crossref","first-page":"1089539","DOI":"10.3389\/fphys.2022.1089539","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Fu R, Wen X, Wang Q, Huang X, Zhang L. The significant clinical correlation of the intratumor oral microbiome in oral squamous cell carcinoma based on tissue-derived sequencing. Front Physiol. 2022;13:1089539.","journal-title":"Front Physiol"},{"key":"840_CR87","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41598-017-02079-3","volume":"7","author":"NN Al-Hebshi","year":"2017","unstructured":"Al-Hebshi NN, Nasher AT, Maryoud MY, Homeida HE, Chen T, Idris AM, Johnson NW. Inflammatory bacteriome featuring Fusobacterium nucleatum and Pseudomonas aeruginosa identified in association with oral squamous cell carcinoma. Sci Rep. 2017;7:1834.","journal-title":"Sci Rep"},{"key":"840_CR88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/carcin\/bgaa062","volume":"42","author":"SC Su","year":"2021","unstructured":"Su SC, Chang LC, Huang HD, Peng CY, Chuang CY, Chen YT, Lu MY, Chiu YW, Chen PY, Yang SF. Oral microbial dysbiosis and its performance in predicting oral cancer. Carcinogenesis. 2021;42:127\u201335.","journal-title":"Carcinogenesis"},{"issue":"19","key":"840_CR89","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.3390\/cancers17193247","volume":"17","author":"KR Risoen","year":"2025","unstructured":"Risoen KR, Shaw CA, Chien J, Weimer BC. Fusobacterium nucleatum and Its Impact on Colorectal Cancer Chemoresistance: A Meta-Analysis of In Vitro Co-Culture Infections. Cancers (Basel). 2025;17(19):3247.","journal-title":"Cancers (Basel)"},{"key":"840_CR90","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","volume":"357","author":"LT Geller","year":"2017","unstructured":"Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017;357:1156\u201360.","journal-title":"Science"},{"key":"840_CR91","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12964-024-01909-y","volume":"22","author":"L Dadgar-Zankbar","year":"2024","unstructured":"Dadgar-Zankbar L, Elahi Z, Shariati A, Khaledi A, Razavi S, Khoshbayan A. Exploring the role of Fusobacterium nucleatum in colorectal cancer: implications for tumor proliferation and chemoresistance. Cell Commun Signal. 2024;22:547.","journal-title":"Cell Commun Signal"},{"key":"840_CR92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physiolgenomics.00204.2024","volume":"57","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wang Y, Yang J, Ji L, Yao Y, Ren D, Zhang J. Landscape of the intratumoral microbiota acting on the tumor immune microenvironment in LUAD and LUSC. Physiol Genomics. 2025;57:279\u201391.","journal-title":"Physiol Genomics"},{"key":"840_CR93","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41419-025-08211-w","volume":"17","author":"J Jia","year":"2025","unstructured":"Jia J, Gao W, Wang C, Liu L, Li Y, Sun Z, Yang C, Chen Y, Yu H, Cheng Y. Intratumoral microbiota remodeling of the tumor microenvironment impact solid tumor immunotherapy. Cell Death Dis. 2025;17:62.","journal-title":"Cell Death Dis"},{"key":"840_CR94","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","volume":"8","author":"S Pushalkar","year":"2018","unstructured":"Pushalkar S, Hundeyin M, Daley D, Zambirinis CP, Kurz E, Mishra A, Mohan N, Aykut B, Usyk M, Torres LE, et al. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Cancer Discov. 2018;8:403\u201316.","journal-title":"Cancer Discov"},{"key":"840_CR95","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.immuni.2019.11.009","volume":"51","author":"MA Lauterbach","year":"2019","unstructured":"Lauterbach MA, Hanke JE, Serefidou M, Mangan MSJ, Kolbe CC, Hess T, Rothe M, Kaiser R, Hoss F, Gehlen J, et al. Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate Lyase. Immunity. 2019;51:997\u2013e10111017.","journal-title":"Immunity"},{"key":"840_CR96","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Ding L, Mei J, Hu Y, Kong X, Dai S, Bu T, Xiao Q, Ding K. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther. 2025;10:268.","journal-title":"Signal Transduct Target Ther"},{"key":"840_CR97","doi-asserted-by":"crossref","first-page":"16295","DOI":"10.1002\/cam4.6242","volume":"12","author":"C Wang","year":"2023","unstructured":"Wang C, Shen N, Guo Q, Tan X, He S. YAP\/STAT3 inhibited CD8(+) T cells activity in the breast cancer immune microenvironment by inducing M2 polarization of tumor-associated macrophages. Cancer Med. 2023;12:16295\u2013309.","journal-title":"Cancer Med"},{"key":"840_CR98","first-page":"8389","volume":"10","author":"J Wang","year":"2017","unstructured":"Wang J, Huang H, Lu J, Bi P, Wang F, Liu X, Zhang B, Luo Y, Li X. Tumor cells induced-M2 macrophage favors accumulation of Treg in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2017;10:8389\u2013401.","journal-title":"Int J Clin Exp Pathol"},{"key":"840_CR99","doi-asserted-by":"crossref","first-page":"e71753","DOI":"10.1096\/fj.202502538RR","volume":"40","author":"P Zhu","year":"2026","unstructured":"Zhu P, Tian Z, Wang Y, Liao H, Mi Z. Lactate Activates TGF-\u03b2\/SNAIL Signaling to Drive M2 Macrophage Polarization and CD8(+) T Cell Exhaustion in Breast Cancer. Faseb j. 2026;40:e71753.","journal-title":"Faseb j"},{"key":"840_CR100","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1158\/2326-6066.CIR-19-1005","volume":"8","author":"V Bronte","year":"2020","unstructured":"Bronte V. Macrophages Instruct Aberrant Glycosylation in Colon Cancer by Chemokine and Cytokine Signals. Cancer Immunol Res. 2020;8:160.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"840_CR101","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41389-026-00632-2","volume":"15","author":"Z Wang","year":"2026","unstructured":"Wang Z, Tang M, Konopleva M. Anti-apoptotic BCL-2 family proteins: from regulatory networks to therapeutic targeting. Oncogenesis. 2026;15(1):43.","journal-title":"Oncogenesis"},{"key":"840_CR102","doi-asserted-by":"crossref","first-page":"1654947","DOI":"10.3389\/fimmu.2025.1654947","volume":"16","author":"C Zhang","year":"2025","unstructured":"Zhang C, Liu W, Yang P, Lin R, Pu L, Zhang H. Dual roles of innate immune cells and cytokines in shaping the breast cancer microenvironment. Front Immunol. 2025;16:1654947.","journal-title":"Front Immunol"},{"key":"840_CR103","doi-asserted-by":"crossref","first-page":"1676338","DOI":"10.3389\/fcell.2025.1676338","volume":"13","author":"X Liu","year":"2025","unstructured":"Liu X, Yu Q. Advances in tumor-associated macrophage-mediated chemotherapeutic resistance in glioma. Front Cell Dev Biol. 2025;13:1676338.","journal-title":"Front Cell Dev Biol"},{"key":"840_CR104","doi-asserted-by":"crossref","first-page":"1980347","DOI":"10.1080\/19490976.2021.1980347","volume":"13","author":"C Xu","year":"2021","unstructured":"Xu C, Fan L, Lin Y, Shen W, Qi Y, Zhang Y, Chen Z, Wang L, Long Y, Hou T, et al. Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322\/CCL20 axis and M2 polarization. Gut Microbes. 2021;13:1980347.","journal-title":"Gut Microbes"},{"issue":"1","key":"840_CR105","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41419-026-08756-4","volume":"17","author":"K Fragkoulis","year":"2026","unstructured":"Fragkoulis K, \u0141asut-Szyszka B, V\u00e9gv\u00e1ri \u00c1, Ayona D, Saei AA, Aschtgen MS, Peuget S. Klebsiella pneumoniae LPS drives stromal-mediated repression of p53 and colorectal cancer chemoresistance. Cell Death Dis. 2026;17(1):395.","journal-title":"Cell Death Dis"},{"key":"840_CR106","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00262-025-03965-w","volume":"74","author":"H Khizar","year":"2025","unstructured":"Khizar H, Ali K, Wang J. From silent partners to potential therapeutic targets: macrophages in colorectal cancer. Cancer Immunol Immunother. 2025;74:121.","journal-title":"Cancer Immunol Immunother"},{"key":"840_CR107","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2022.01.002","volume":"172","author":"RMS Haegebaert","year":"2022","unstructured":"Haegebaert RMS, Kempers M, Ceelen W, Lentacker I, Remaut K. Nanoparticle mediated targeting of toll-like receptors to treat colorectal cancer. Eur J Pharm Biopharm. 2022;172:16\u201330.","journal-title":"Eur J Pharm Biopharm"},{"key":"840_CR108","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s12672-025-02509-z","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Tang T, Sun Y, Chen G, Yuan X, Cai D. The role of TLR-4 in chemoresistance of cancer. Discov Oncol. 2025;16:865.","journal-title":"Discov Oncol"},{"key":"840_CR109","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-025-02521-5","volume":"25","author":"H Liu","year":"2025","unstructured":"Liu H, Xiong X, Zhu W, Wang S, Huang W, Zhu G, Xu H, Yang L. Gut microbial metabolites in cancer immunomodulation. Mol Cancer. 2025;25:8.","journal-title":"Mol Cancer"},{"key":"840_CR110","doi-asserted-by":"crossref","first-page":"100773","DOI":"10.1016\/j.medj.2025.100773","volume":"6","author":"M Perl","year":"2025","unstructured":"Perl M, Fante MA, Herfeld K, Scherer JN, Poeck H, Thiele Orberg E. Microbiota-derived metabolites: Key modulators of cancer immunotherapies. Med. 2025;6:100773.","journal-title":"Med"},{"issue":"5","key":"840_CR111","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10408363.2025.2602551","volume":"63","author":"L Duan","year":"2026","unstructured":"Duan L, Hu D, Zhang H, Liao Y. Microbiota and tumor epigenetics: deep interconnections and emerging therapeutic perspectives. Crit Rev Clin Lab Sci. 2026;63(5):433\u201373.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"840_CR112","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","volume":"8","author":"L Yang","year":"2023","unstructured":"Yang L, Li A, Wang Y, Zhang Y. Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy. Signal Transduct Target Ther. 2023;8:35.","journal-title":"Signal Transduct Target Ther"},{"key":"840_CR113","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang H, Rong X, Zhao G, Zhou Y, Xiao Y, Ma D, Jin X, Wu Y, Yan Y, Yang H, et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 2022;34:581\u2013e594588.","journal-title":"Cell Metab"},{"key":"840_CR114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","volume":"14","author":"MR Rubinstein","year":"2013","unstructured":"Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195\u2013206.","journal-title":"Cell Host Microbe"},{"key":"840_CR115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.ircmb.2025.08.002","volume":"400","author":"A Barzegar Behrooz","year":"2026","unstructured":"Barzegar Behrooz A, Cordani M, Ghavami S. Epigenetic regulation of autophagy in cancer: A double-edged sword in tumor progression and therapy resistance. Int Rev Cell Mol Biol. 2026;400:63\u2013105.","journal-title":"Int Rev Cell Mol Biol"},{"key":"840_CR116","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41419-024-06945-7","volume":"15","author":"N Li","year":"2024","unstructured":"Li N, Zuo R, He Y, Gong W, Wang Y, Chen L, Luo Y, Zhang C, Liu Z, Chen P, Guo H. PD-L1 induces autophagy and primary resistance to EGFR-TKIs in EGFR-mutant lung adenocarcinoma via the MAPK signaling pathway. Cell Death Dis. 2024;15:555.","journal-title":"Cell Death Dis"},{"issue":"1","key":"840_CR117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12943-026-02583-z","volume":"25","author":"Y Zhou","year":"2026","unstructured":"Zhou Y, Bai M, Chen L, Han H, Hou S, Wang X, Fan P, Han S, Chen F, Li J, et al. Targeting inflammatory microenvironments: overcoming therapy resistance and immunosuppression. Mol Cancer. 2026;25(1):81.","journal-title":"Mol Cancer"},{"key":"840_CR118","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2016.10.005","volume":"44","author":"CV Rosadini","year":"2017","unstructured":"Rosadini CV, Kagan JC. Early innate immune responses to bacterial LPS. Curr Opin Immunol. 2017;44:14\u20139.","journal-title":"Curr Opin Immunol"},{"key":"840_CR119","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/35074106","volume":"410","author":"F Hayashi","year":"2001","unstructured":"Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410:1099\u2013103.","journal-title":"Nature"},{"key":"840_CR120","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1016\/j.apsb.2021.04.019","volume":"11","author":"J Chen","year":"2021","unstructured":"Chen J, Qiao Y, Chen G, Chang C, Dong H, Tang B, Cheng X, Liu X, Hua Z. Salmonella flagella confer anti-tumor immunological effect via activating Flagellin\/TLR5 signalling within tumor microenvironment. Acta Pharm Sin B. 2021;11:3165\u201377.","journal-title":"Acta Pharm Sin B"},{"key":"840_CR121","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.tim.2011.08.004","volume":"19","author":"AS Neish","year":"2011","unstructured":"Neish AS, Naumann M. Microbial-induced immunomodulation by targeting the NF-kappaB system. Trends Microbiol. 2011;19:596\u2013605.","journal-title":"Trends Microbiol"},{"key":"840_CR122","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrmicro2539","volume":"9","author":"MM Rahman","year":"2011","unstructured":"Rahman MM, McFadden G. Modulation of NF-kappaB signalling by microbial pathogens. Nat Rev Microbiol. 2011;9:291\u2013306.","journal-title":"Nat Rev Microbiol"},{"key":"840_CR123","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40164-024-00529-z","volume":"13","author":"Q Ma","year":"2024","unstructured":"Ma Q, Hao S, Hong W, Tergaonkar V, Sethi G, Tian Y, Duan C. Versatile function of NF-\u0138B in inflammation and cancer. Exp Hematol Oncol. 2024;13:68.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR124","first-page":"1","volume":"55","author":"Q Cheng","year":"2026","unstructured":"Cheng Q, Zhu Y, Lv S, Shi J, Kuang M, Wang L, Ji X. Engineered bacteria and bacteria-derived nanomaterials for cancer therapy: Mechanisms, designs and advances. Bioact Mater. 2026;55:1\u201322.","journal-title":"Bioact Mater"},{"key":"840_CR125","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.ccell.2025.07.002","volume":"43","author":"ZY Wu","year":"2025","unstructured":"Wu ZY, Wu QW, Han Y, Xiang SJ, Wang YN, Wu WW, Chen YX, Feng ZQ, Wang YY, Xu ZG, et al. Alistipes finegoldii augments the efficacy of immunotherapy against solid tumors. Cancer Cell. 2025;43:1714\u2013e17301712.","journal-title":"Cancer Cell"},{"key":"840_CR126","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.cell.2021.09.019","volume":"184","author":"KC Lam","year":"2021","unstructured":"Lam KC, Araya RE, Huang A, Chen Q, Di Modica M, Rodrigues RR, Lop\u00e8s A, Johnson SB, Schwarz B, Bohrnsen E, et al. Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment. Cell. 2021;184:5338\u2013e53565321.","journal-title":"Cell"},{"key":"840_CR127","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cac2.70067","volume":"45","author":"Y Yan","year":"2025","unstructured":"Yan Y, Tan X, Song B, Yi M, Chu Q, Wu K. Breaking barriers: The cGAS-STING pathway as a novel frontier in cancer immunotherapy. Cancer Commun (Lond). 2025;45:1513\u201346.","journal-title":"Cancer Commun (Lond)"},{"key":"840_CR128","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13045-022-01363-8","volume":"15","author":"M Yi","year":"2022","unstructured":"Yi M, Niu M, Wu Y, Ge H, Jiao D, Zhu S, Zhang J, Yan Y, Zhou P, Chu Q, Wu K. Combination of oral STING agonist MSA-2 and anti-TGF-\u03b2\/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors. J Hematol Oncol. 2022;15:142.","journal-title":"J Hematol Oncol"},{"key":"840_CR129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40164-024-00502-w","volume":"13","author":"AM Khalifa","year":"2024","unstructured":"Khalifa AM, Nakamura T, Sato Y, Harashima H. Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11b(high)CD27(low) memory-like NK cells. Exp Hematol Oncol. 2024;13:36.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillere R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91\u20137.","journal-title":"Science"},{"key":"840_CR131","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.micinf.2007.05.010","volume":"9","author":"KW Bruhn","year":"2007","unstructured":"Bruhn KW, Craft N, Miller JF. Listeria as a vaccine vector. Microbes Infect. 2007;9:1226\u201335.","journal-title":"Microbes Infect"},{"key":"840_CR132","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s43018-025-00919-0","volume":"6","author":"BR Schrank","year":"2025","unstructured":"Schrank BR, Wang Y, Wu A, Tran N, Lee D, Edwards J, Huntoon K, Dong S, Ha J, Ma Y, et al. An antibody-toxin conjugate targeting CD47 linked to the bacterial toxin listeriolysin O for cancer immunotherapy. Nat Cancer. 2025;6:511\u201327.","journal-title":"Nat Cancer"},{"key":"840_CR133","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12915-024-02086-7","volume":"22","author":"J Sun","year":"2024","unstructured":"Sun J, Wang J, Jiang X, Xia J, Han Y, Chen M, Xu J, Deng S, Cheng C, Song H. LADS: a powerful vaccine platform for cancer immunotherapy and prevention. BMC Biol. 2024;22:291.","journal-title":"BMC Biol"},{"key":"840_CR134","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s42003-024-05853-y","volume":"7","author":"CW Wold","year":"2024","unstructured":"Wold CW, Christopoulos PF, Arias MA, Dzovor DE, Oynebraten I, Corthay A, Inngjerdingen KT. Fungal polysaccharides from Inonotus obliquus are agonists for Toll-like receptors and induce macrophage anti-cancer activity. Commun Biol. 2024;7:222.","journal-title":"Commun Biol"},{"key":"840_CR135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/mlf2.12118","volume":"3","author":"Y Guan","year":"2024","unstructured":"Guan Y, Wu D, Wang H, Liu NN. Microbiome-driven anticancer therapy: A step forward from natural products. mLife. 2024;3:219\u201330.","journal-title":"mLife"},{"key":"840_CR136","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2021.03.053","volume":"151","author":"G Zhu","year":"2021","unstructured":"Zhu G, Su H, Johnson CH, Khan SA, Kluger H, Lu L. Intratumour microbiome associated with the infiltration of cytotoxic CD8\u2009+\u2009T cells and patient survival in cutaneous melanoma. Eur J Cancer. 2021;151:25\u201334.","journal-title":"Eur J Cancer"},{"key":"840_CR137","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41419-023-05560-2","volume":"14","author":"AH Mohseni","year":"2023","unstructured":"Mohseni AH, Taghinezhad SS, Casolaro V, Lv Z, Li D. Potential links between the microbiota and T cell immunity determine the tumor cell fate. Cell Death Dis. 2023;14:154.","journal-title":"Cell Death Dis"},{"key":"840_CR138","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1111\/cas.15782","volume":"114","author":"T Higuchi","year":"2023","unstructured":"Higuchi T, Hashida Y, Matsuo K, Kitahata K, Ujihara T, Murakami I, Nakayama T, Daibata M. EBV-positive pyothorax-associated lymphoma expresses CXCL9 and CXCL10 chemokines that attract cytotoxic lymphocytes via CXCR3. Cancer Sci. 2023;114:2622\u201333.","journal-title":"Cancer Sci"},{"key":"840_CR139","first-page":"0127","volume":"6","author":"N Liu","year":"2023","unstructured":"Liu N, Chen L, Yan M, Tao Q, Wu J, Chen J, Chen X, Zhang W, Peng C. Eubacterium rectale Improves the Efficacy of Anti-PD1 Immunotherapy in Melanoma via l-Serine-Mediated NK Cell Activation. Res (Wash D C). 2023;6:0127.","journal-title":"Res (Wash D C)"},{"key":"840_CR140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41392-024-01771-x","volume":"9","author":"YL Xiao","year":"2024","unstructured":"Xiao YL, Gong Y, Qi YJ, Shao ZM, Jiang YZ. Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential. Signal Transduct Target Ther. 2024;9:59.","journal-title":"Signal Transduct Target Ther"},{"key":"840_CR141","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.immuni.2021.11.003","volume":"54","author":"AE Overacre-Delgoffe","year":"2021","unstructured":"Overacre-Delgoffe AE, Bumgarner HJ, Cillo AR, Burr AHP, Tometich JT, Bhattacharjee A, Bruno TC, Vignali DAA, Hand TW. Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer. Immunity. 2021;54:2812\u2013e28242814.","journal-title":"Immunity"},{"key":"840_CR142","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.4110\/in.2023.23.e7","volume":"23","author":"C Lee","year":"2023","unstructured":"Lee C, Lee H, Park JC, Im SH. Microbial Components and Effector Molecules in T Helper Cell Differentiation and Function. Immune Netw. 2023;23:e7.","journal-title":"Immune Netw"},{"key":"840_CR143","doi-asserted-by":"crossref","first-page":"eabo2296","DOI":"10.1126\/science.abo2296","volume":"380","author":"M Fidelle","year":"2023","unstructured":"Fidelle M, Rauber C, Alves Costa Silva C, Tian AL, Lahmar I, de La Varende AM, Zhao L, Thelemaque C, Lebhar I, Messaoudene M, et al. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers. Science. 2023;380:eabo2296.","journal-title":"Science"},{"key":"840_CR144","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-025-09913-z","volume":"651","author":"TA Najar","year":"2026","unstructured":"Najar TA, Hao Y, Hao Y, Romero-Meza G, Dolynuk A, Almo E, Littman DR. Microbiota-induced T cell plasticity enables immune-mediated tumour control. Nature. 2026;651:201\u201310.","journal-title":"Nature"},{"key":"840_CR145","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"Kalaora S, Nagler A, Nejman D, Alon M, Barbolin C, Barnea E, Ketelaars SLC, Cheng K, Vervier K, Shental N, et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature. 2021;592:138\u201343.","journal-title":"Nature"},{"key":"840_CR146","doi-asserted-by":"publisher","first-page":"13477","DOI":"10.1007\/s00432-023-05199-8","volume":"149","author":"S Fan","year":"2023","unstructured":"Fan S, Jiang Z, Zhang Z, Xing J, Wang D, Tang D. Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy. J Cancer Res Clin Oncol. 2023;149:13477\u201394.","journal-title":"J Cancer Res Clin Oncol"},{"key":"840_CR147","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40164-024-00539-x","volume":"13","author":"Y Yin","year":"2024","unstructured":"Yin Y, Feng W, Chen J, Chen X, Wang G, Wang S, Xu X, Nie Y, Fan D, Wu K, Xia L. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside. Exp Hematol Oncol. 2024;13:72.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR148","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","volume":"13","author":"J Lu","year":"2024","unstructured":"Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, Zhang B, Li Y, Liu B, Xia L, Huang W. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion. Exp Hematol Oncol. 2024;13:39.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR149","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40164-023-00469-0","volume":"13","author":"M Cao","year":"2024","unstructured":"Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J, Liu X, Wang Y, Zhang S, Lu S, et al. The roles of tissue resident macrophages in health and cancer. Exp Hematol Oncol. 2024;13:3.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR150","doi-asserted-by":"crossref","first-page":"15354","DOI":"10.1073\/pnas.1010203108","volume":"108","author":"AC Goodwin","year":"2011","unstructured":"Goodwin AC, Destefano Shields CE, Wu S, Huso DL, Wu X, Murray-Stewart TR, Hacker-Prietz A, Rabizadeh S, Woster PM, Sears CL, Casero RA Jr. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis. Proc Natl Acad Sci U S A. 2011;108:15354\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"840_CR151","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chom.2018.02.004","volume":"23","author":"L Chung","year":"2018","unstructured":"Chung L, Orberg ET, Geis AL, Chan JL, Fu K, DeStefano Shields CE, Dejea CM, Fathi P, Chen J, Finard BB, et al. Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells. Cell Host Microbe. 2018;23:421.","journal-title":"Cell Host Microbe"},{"key":"840_CR152","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jcmgh.2024.01.010","volume":"17","author":"Y Miyakawa","year":"2024","unstructured":"Miyakawa Y, Otsuka M, Shibata C, Seimiya T, Yamamoto K, Ishibashi R, Kishikawa T, Tanaka E, Isagawa T, Takeda N, et al. Gut Bacteria-derived Membrane Vesicles Induce Colonic Dysplasia by Inducing DNA Damage in Colon Epithelial Cells. Cell Mol Gastroenterol Hepatol. 2024;17:745\u201367.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"840_CR153","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2017.01.009","volume":"152","author":"H Tsoi","year":"2017","unstructured":"Tsoi H, Chu ESH, Zhang X, Sheng J, Nakatsu G, Ng SC, Chan AWH, Chan FKL, Sung JJY, Yu J. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology. 2017;152:1419\u2013e14331415.","journal-title":"Gastroenterology"},{"key":"840_CR154","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, Ameh S, Sandel D, Liang XS, Mazzilli S, et al. Commensal Microbiota Promote Lung Cancer Development via gammadelta T Cells. Cell. 2019;176:998\u2013e10131016.","journal-title":"Cell"},{"key":"840_CR155","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1158\/0008-5472.CAN-13-2462","volume":"74","author":"M Cheng","year":"2014","unstructured":"Cheng M, Qian L, Shen G, Bian G, Xu T, Xu W, Shen G, Hu S. Microbiota modulate tumoral immune surveillance in lung through a gammadeltaT17 immune cell-dependent mechanism. Cancer Res. 2014;74:4030\u201341.","journal-title":"Cancer Res"},{"key":"840_CR156","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ccell.2023.12.006","volume":"42","author":"V Chandra","year":"2024","unstructured":"Chandra V, Li L, Le Roux O, Zhang Y, Howell RM, Rupani DN, Baydogan S, Miller HD, Riquelme E, Petrosino J, et al. Gut epithelial Interleukin-17 receptor A signaling can modulate distant tumors growth through microbial regulation. Cancer Cell. 2024;42:85\u2013e100106.","journal-title":"Cancer Cell"},{"key":"840_CR157","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.3748\/wjg.v24.i47.5351","volume":"24","author":"MA Proen\u00e7a","year":"2018","unstructured":"Proen\u00e7a MA, Biselli JM, Succi M, Severino FE, Berardinelli GN, Caetano A, Reis RM, Hughes DJ, Silva AE. Relationship between Fusobacterium nucleatum, inflammatory mediators and microRNAs in colorectal carcinogenesis. World J Gastroenterol. 2018;24:5351\u201365.","journal-title":"World J Gastroenterol"},{"key":"840_CR158","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/IAI.01226-13","volume":"82","author":"SR Park","year":"2014","unstructured":"Park SR, Kim DJ, Han SH, Kang MJ, Lee JY, Jeong YJ, Lee SJ, Kim TH, Ahn SG, Yoon JH, Park JH. Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages. Infect Immun. 2014;82:1914\u201320.","journal-title":"Infect Immun"},{"key":"840_CR159","doi-asserted-by":"crossref","first-page":"1795703","DOI":"10.3389\/fimmu.2026.1795703","volume":"17","author":"W Wuyi","year":"2026","unstructured":"Wuyi W, Tao P. Microbe-driven immune suppression in colorectal cancer: the Fusobacterium nucleatum playbook. Front Immunol. 2026;17:1795703.","journal-title":"Front Immunol"},{"key":"840_CR160","doi-asserted-by":"crossref","first-page":"1549564","DOI":"10.3389\/fimmu.2025.1549564","volume":"16","author":"W Zheng","year":"2025","unstructured":"Zheng W, Wang Y, Sun H, Bao S, Ge S, Quan C. The role of Fusobacterium nucleatum in macrophage M2 polarization and NF-kappaB pathway activation in colorectal cancer. Front Immunol. 2025;16:1549564.","journal-title":"Front Immunol"},{"key":"840_CR161","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/s41467-020-16967-2","volume":"11","author":"L Parhi","year":"2020","unstructured":"Parhi L, Alon-Maimon T, Sol A, Nejman D, Shhadeh A, Fainsod-Levi T, Yajuk O, Isaacson B, Abed J, Maalouf N, et al. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression. Nat Commun. 2020;11:3259.","journal-title":"Nat Commun"},{"key":"840_CR162","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42:344\u201355.","journal-title":"Immunity"},{"key":"840_CR163","doi-asserted-by":"crossref","first-page":"111168","DOI":"10.1016\/j.humimm.2024.111168","volume":"85","author":"J Guo","year":"2024","unstructured":"Guo J, Zhu P, Li J, Xu L, Tang Y, Liu X, Guo S, Xia J. Fusobacterium nucleatum promotes PD-L1 expression in cancer cells to evade CD8(+) T cell killing in breast cancer. Hum Immunol. 2024;85:111168.","journal-title":"Hum Immunol"},{"key":"840_CR164","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/2326-6066.CIR-22-0107","volume":"10","author":"R Peng","year":"2022","unstructured":"Peng R, Liu S, You W, Huang Y, Hu C, Gao Y, Jia X, Li G, Xu Z, Chen Y. Gastric Microbiome Alterations Are Associated with Decreased CD8\u2009+\u2009Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer. Cancer Immunol Res. 2022;10:1224\u201340.","journal-title":"Cancer Immunol Res"},{"key":"840_CR165","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40164-024-00558-8","volume":"13","author":"H Wang","year":"2024","unstructured":"Wang H, Yung MM, Xuan Y, Chen F, Chan W, Siu MK, Long R, Jia S, Liang Y, Xu D, et al. Polyunsaturated fatty acids promote M2-like TAM deposition via dampening RhoA-YAP1 signaling in the ovarian cancer microenvironment. Exp Hematol Oncol. 2024;13:90.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR166","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41419-021-04293-4","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, Pu N, Chen Q, Zhang J, Zhao G, Xu X, Wang D, Kuang T, Jin D, Lou W, Wu W. Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4\/MyD88\/AKT\/NF-kappaB pathway in pancreatic cancer. Cell Death Dis. 2021;12:1033.","journal-title":"Cell Death Dis"},{"key":"840_CR167","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1038\/s41467-024-51534-z","volume":"15","author":"ZY Han","year":"2024","unstructured":"Han ZY, Fu ZJ, Wang YZ, Zhang C, Chen QW, An JX, Zhang XZ. Probiotics functionalized with a gallium-polyphenol network modulate the intratumor microbiota and promote anti-tumor immune responses in pancreatic cancer. Nat Commun. 2024;15:7096.","journal-title":"Nat Commun"},{"key":"840_CR168","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40164-025-00689-6","volume":"14","author":"R Wang","year":"2025","unstructured":"Wang R, Zhuang J, Zhang Q, Wu W, Yu X, Zhang H, Xie Z. Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies. Exp Hematol Oncol. 2025;14:99.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR169","doi-asserted-by":"crossref","first-page":"e72171","DOI":"10.7554\/eLife.72171","volume":"10","author":"SP Thomas","year":"2021","unstructured":"Thomas SP, Denu JM. Short-chain fatty acids activate acetyltransferase p300. Elife. 2021;10:e72171.","journal-title":"Elife"},{"key":"840_CR170","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, Reichardt N, Yuille S, Busetti A, Klein M, Wempe A, Leister H, Raifer H, et al. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12:4077.","journal-title":"Nat Commun"},{"key":"840_CR171","doi-asserted-by":"crossref","first-page":"2609455","DOI":"10.1080\/19490976.2025.2609455","volume":"18","author":"J Wang","year":"2026","unstructured":"Wang J, Zi F, Liu W, Liu C, Zhang Z, Kong L, Xu X, Wei J, Chen T, Li J. Clostridium butyricum alleviates multiple myeloma by remodeling the bone marrow microenvironment and inhibiting PI3K\/AKT pathway through the gut\u2013bone axis. Gut Microbes. 2026;18:2609455.","journal-title":"Gut Microbes"},{"key":"840_CR172","doi-asserted-by":"publisher","first-page":"11919","DOI":"10.1038\/s41598-025-97038-8","volume":"15","author":"H Konishi","year":"2025","unstructured":"Konishi H, Saito T, Takahashi S, Tanaka H, Okuda K, Akutsu H, Dokoshi T, Sakatani A, Takahashi K, Ando K, et al. The butyrate derived from probiotic Clostridium butyricum exhibits an inhibitory effect on multiple myeloma through cell death induction. Sci Rep. 2025;15:11919.","journal-title":"Sci Rep"},{"key":"840_CR173","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1038\/s41388-021-01978-0","volume":"40","author":"J Su","year":"2021","unstructured":"Su J, Wu G, Ye Y, Zhang J, Zeng L, Huang X, Zheng Y, Bai R, Zhuang L, Li M, et al. NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization. Oncogene. 2021;40:5814\u201328.","journal-title":"Oncogene"},{"key":"840_CR174","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cmet.2022.02.010","volume":"34","author":"H Wang","year":"2022","unstructured":"Wang H, Rong X, Zhao G, Zhou Y, Xiao Y, Ma D, Jin X, Wu Y, Yan Y, Yang H, et al. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer. Cell Metab. 2022;34:581\u2013e594588.","journal-title":"Cell Metab"},{"key":"840_CR175","first-page":"7043856","volume":"2022","author":"S Yang","year":"2022","unstructured":"Yang S, Dai H, Lu Y, Li R, Gao C, Pan S. Trimethylamine N-Oxide Promotes Cell Proliferation and Angiogenesis in Colorectal Cancer. J Immunol Res. 2022;2022:7043856.","journal-title":"J Immunol Res"},{"key":"840_CR176","doi-asserted-by":"crossref","first-page":"840236","DOI":"10.3389\/fmicb.2022.840236","volume":"13","author":"PM Tran","year":"2022","unstructured":"Tran PM, Tang SS, Salgado-Pab\u00f3n W. Staphylococcus aureus \u03b2-Toxin Exerts Anti-angiogenic Effects by Inhibiting Re-endothelialization and Neovessel Formation. Front Microbiol. 2022;13:840236.","journal-title":"Front Microbiol"},{"key":"840_CR177","doi-asserted-by":"crossref","first-page":"1550516","DOI":"10.3389\/fmicb.2025.1550516","volume":"16","author":"S Rui","year":"2025","unstructured":"Rui S, Fengrui G, Yining Z, Hong S, Xuewen Y, Changping W, Chunjia Y. Biological activity of secondary metabolites of actinomycetes and their potential sources as antineoplastic drugs: a review. Front Microbiol. 2025;16:1550516.","journal-title":"Front Microbiol"},{"key":"840_CR178","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s42255-022-00558-0","volume":"4","author":"D Ternes","year":"2022","unstructured":"Ternes D, Tsenkova M, Pozdeev VI, Meyers M, Koncina E, Atatri S, Schmitz M, Karta J, Schmoetten M, Heinken A, et al. The gut microbial metabolite formate exacerbates colorectal cancer progression. Nat Metab. 2022;4:458\u201375.","journal-title":"Nat Metab"},{"key":"840_CR179","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.1007\/s11010-025-05281-4","volume":"480","author":"HX Lin","year":"2025","unstructured":"Lin HX, Tang YL, Liang XH. Decoding STING\u2019s roles in cancer: immunity, pain, dormancy, and autophagy. Mol Cell Biochem. 2025;480:4697\u2013723.","journal-title":"Mol Cell Biochem"},{"key":"840_CR180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1515\/mr-2023-0061","volume":"4","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Huang S, Fan F, Xu Y, Moore C, Li S, Han C. The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges. Med Rev (2021). 2024;4:173\u201391.","journal-title":"Med Rev (2021)"},{"key":"840_CR181","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.cmet.2023.04.015","volume":"35","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhao Q, Li T, Lu L, Wang F, Zhang H, Liu Z, Ma H, Zhu Q, Wang J, et al. Lactobacillus plantarum-derived indole-3-lactic acid ameliorates colorectal tumorigenesis via epigenetic regulation of CD8(+) T cell immunity. Cell Metab. 2023;35:943\u2013e960949.","journal-title":"Cell Metab"},{"key":"840_CR182","doi-asserted-by":"crossref","first-page":"116132","DOI":"10.1016\/j.celrep.2025.116132","volume":"44","author":"Q Song","year":"2025","unstructured":"Song Q, Li X, Li Q, Shang S, Ma S, Zhai Z, Sun F, Mo Y, Wei L, Wu M, et al. Bifidobacterium animalis suppresses non-small cell lung cancer progression and modulates tumor immunity through indole-3-acetic acid. Cell Rep. 2025;44:116132.","journal-title":"Cell Rep"},{"key":"840_CR183","doi-asserted-by":"crossref","first-page":"1780972","DOI":"10.3389\/fimmu.2026.1780972","volume":"17","author":"Y Dong","year":"2026","unstructured":"Dong Y, Ma Y, Yu Q, Shi Z, Wang C, Che Y, Liu H, Wan D, Shao W, Xiao H. Inosine alleviates colorectal cancer liver metastasis by promoting M1 macrophage polarization and modulating the PI3K\/AKT signaling pathway. Front Immunol. 2026;17:1780972.","journal-title":"Front Immunol"},{"key":"840_CR184","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s13059-022-02828-2","volume":"23","author":"B Kang","year":"2022","unstructured":"Kang B, Camps J, Fan B, Jiang H, Ibrahim MM, Hu X, Qin S, Kirchhoff D, Chiang DY, Wang S, et al. Parallel single-cell and bulk transcriptome analyses reveal key features of the gastric tumor microenvironment. Genome Biol. 2022;23:265.","journal-title":"Genome Biol"},{"key":"840_CR185","doi-asserted-by":"crossref","first-page":"218016","DOI":"10.1016\/j.canlet.2025.218016","volume":"633","author":"S Jiang","year":"2025","unstructured":"Jiang S, Ren B, Ding C, Du C, Cao Z, Yang G, Huang H, Zhang T. Polyamines in pancreatic cancer: reshaping the immunosuppressive tumor microenvironment. Cancer Lett. 2025;633:218016.","journal-title":"Cancer Lett"},{"key":"840_CR186","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41419-025-07640-x","volume":"16","author":"J Yu","year":"2025","unstructured":"Yu J, Zhang C, Zhang Q, Lu B, Lu G, Zhang C, Qiu R, Wang X, Zou C, Chu J, et al. AZIN1-dependent polyamine synthesis accelerates tumor cell cycle progression and impairs effector T-cell function in osteosarcoma. Cell Death Dis. 2025;16:310.","journal-title":"Cell Death Dis"},{"issue":"1","key":"840_CR187","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41419-026-08722-0","volume":"17","author":"H Tao","year":"2026","unstructured":"Tao H, Wang X, Hu Z, Li Y, Kong M, Sun Y, Gao K, Wan X. ARID1A deficiency-driven reprogramming of polyamine metabolism promotes endometrial cancer malignancy and immune escape. Cell Death Dis. 2026;17(1):484.","journal-title":"Cell Death Dis"},{"key":"840_CR188","doi-asserted-by":"crossref","first-page":"1710880","DOI":"10.3389\/fimmu.2025.1710880","volume":"16","author":"W Luo","year":"2025","unstructured":"Luo W, Li R, Pan C, Luo C. Gut microbiota\u2013derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy. Front Immunol. 2025;16:1710880.","journal-title":"Front Immunol"},{"key":"840_CR189","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41467-025-67502-0","volume":"17","author":"H Zhou","year":"2025","unstructured":"Zhou H, Chen H, Liu W, Liang C, Wang S, Yuan K, Cheung AHK, Wu Y, Kang W, Cheung H, et al. Targeting of the m(6)A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer. Nat Commun. 2025;17:803.","journal-title":"Nat Commun"},{"key":"840_CR190","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1007\/s11427-025-3019-2","volume":"68","author":"H Zhang","year":"2025","unstructured":"Zhang H, Wen J, Liu X, Feng YQ, Liu X, Ning K. Microbial bile acid modifications: current understandings, key problems, and future perspectives. Sci China Life Sci. 2025;68:3600\u201316.","journal-title":"Sci China Life Sci"},{"key":"840_CR191","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fphar.2018.00939","volume":"9","author":"TM \u0160arenac","year":"2018","unstructured":"\u0160arenac TM, Mikov M. Bile Acid Synthesis: From Nature to the Chemical Modification and Synthesis and Their Applications as Drugs and Nutrients. Front Pharmacol. 2018;9:939.","journal-title":"Front Pharmacol"},{"key":"840_CR192","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.apsb.2015.01.006","volume":"5","author":"JM Ridlon","year":"2015","unstructured":"Ridlon JM, Bajaj JS. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharm Sin B. 2015;5:99\u2013105.","journal-title":"Acta Pharm Sin B"},{"key":"840_CR193","doi-asserted-by":"crossref","first-page":"106101","DOI":"10.1016\/j.phrs.2022.106101","volume":"177","author":"S Guo","year":"2022","unstructured":"Guo S, Peng Y, Lou Y, Cao L, Liu J, Lin N, Cai S, Kang Y, Zeng S, Yu L. Downregulation of the farnesoid X receptor promotes colorectal tumorigenesis by facilitating enterotoxigenic Bacteroides fragilis colonization. Pharmacol Res. 2022;177:106101.","journal-title":"Pharmacol Res"},{"key":"840_CR194","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","volume":"57","author":"J Cong","year":"2024","unstructured":"Cong J, Liu P, Han Z, Ying W, Li C, Yang Y, Wang S, Yang J, Cao F, Shen J, et al. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions. Immunity. 2024;57:876\u2013e889811.","journal-title":"Immunity"},{"key":"840_CR195","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","volume":"581","author":"C Campbell","year":"2020","unstructured":"Campbell C, McKenney PT, Konstantinovsky D, Isaeva OI, Schizas M, Verter J, Mai C, Jin WB, Guo CJ, Violante S, et al. Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells. Nature. 2020;581:475\u20139.","journal-title":"Nature"},{"key":"840_CR196","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1126\/science.adl4100","volume":"387","author":"SK Varanasi","year":"2025","unstructured":"Varanasi SK, Chen D, Liu Y, Johnson MA, Miller CM, Ganguly S, Lande K, LaPorta MA, Hoffmann FA, Mann TH, et al. Bile acid synthesis impedes tumor-specific T cell responses during liver cancer. Science. 2025;387:192\u2013201.","journal-title":"Science"},{"key":"840_CR197","doi-asserted-by":"crossref","first-page":"1640073","DOI":"10.3389\/fphar.2025.1640073","volume":"16","author":"X Li","year":"2025","unstructured":"Li X, Meng H, Wang H, Zhang Y, Yu W. Indoleamine 2,3-dioxygenase 1 in cancer immunotherapy: from small-molecule inhibition to PROTAC-mediated degradation. Front Pharmacol. 2025;16:1640073.","journal-title":"Front Pharmacol"},{"key":"840_CR198","first-page":"1","volume":"12","author":"F Dong","year":"2020","unstructured":"Dong F, Hao F, Murray IA, Smith PB, Koo I, Tindall AM, Kris-Etherton PM, Gowda K, Amin SG, Patterson AD, Perdew GH. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes. 2020;12:1\u201324.","journal-title":"Gut Microbes"},{"key":"840_CR199","doi-asserted-by":"crossref","first-page":"1209613","DOI":"10.3389\/fnut.2023.1209613","volume":"10","author":"S Li","year":"2023","unstructured":"Li S. Modulation of immunity by tryptophan microbial metabolites. Front Nutr. 2023;10:1209613.","journal-title":"Front Nutr"},{"key":"840_CR200","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J, Weng CH, Gigoux M, Cohen IJ, Redmond D, Mangarin L, Pourpe S, Liu C, et al. Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun. 2020;11:4011.","journal-title":"Nat Commun"},{"key":"840_CR201","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2018.05.005","volume":"431","author":"A Li","year":"2018","unstructured":"Li A, Barsoumian HB, Schoenhals JE, Cushman TR, Caetano MS, Wang X, Valdecanas DR, Niknam S, Younes AI, Li G, et al. Indoleamine 2,3-dioxygenase 1 inhibition targets anti-PD1-resistant lung tumors by blocking myeloid-derived suppressor cells. Cancer Lett. 2018;431:54\u201363.","journal-title":"Cancer Lett"},{"key":"840_CR202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","volume":"70","author":"A Fiore","year":"2021","unstructured":"Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:7\u201314.","journal-title":"Curr Opin Immunol"},{"key":"840_CR203","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1038\/s41467-023-38933-4","volume":"14","author":"JA Turner","year":"2023","unstructured":"Turner JA, Fredrickson MA, D\u2019Antonio M, Katsnelson E, MacBeth M, Van Gulick R, Chimed TS, McCarter M, D\u2019Alessandro A, Robinson WA, et al. Lysophosphatidic acid modulates CD8 T cell immunosurveillance and metabolism to impair anti-tumor immunity. Nat Commun. 2023;14:3214.","journal-title":"Nat Commun"},{"key":"840_CR204","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1038\/onc.2011.595","volume":"31","author":"KJ Jeong","year":"2012","unstructured":"Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, Kang J, Park CG, Han JW, Lee HY. The Rho\/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion. Oncogene. 2012;31:4279\u201389.","journal-title":"Oncogene"},{"key":"840_CR205","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1158\/2159-8290.CD-21-1181","volume":"12","author":"CS Chae","year":"2022","unstructured":"Chae CS, Sandoval TA, Hwang SM, Park ES, Giovanelli P, Awasthi D, Salvagno C, Emmanuelli A, Tan C, Chaudhary V, et al. Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer. Cancer Discov. 2022;12:1904\u201321.","journal-title":"Cancer Discov"},{"key":"840_CR206","doi-asserted-by":"crossref","first-page":"107028","DOI":"10.1016\/j.prostaglandins.2025.107028","volume":"180","author":"VK Gupta","year":"2025","unstructured":"Gupta VK, Gupta K, Sonker P, Mishra M, Kumar A. Role of lysophosphatidic acid in the regulation of immune cells and hematological malignancies. Prostaglandins Other Lipid Mediat. 2025;180:107028.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"840_CR207","doi-asserted-by":"crossref","first-page":"110013","DOI":"10.1016\/j.celrep.2021.110013","volume":"37","author":"E Matas-Rico","year":"2021","unstructured":"Matas-Rico E, Frijlink E, van der Haar \u00c0vila I, Menegakis A, van Zon M, Morris AJ, Koster J, Salgado-Polo F, de Kivit S, Lan\u00e7a T, et al. Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+) T cells. Cell Rep. 2021;37:110013.","journal-title":"Cell Rep"},{"key":"840_CR208","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y. Cancer metabolism and carcinogenesis. Exp Hematol Oncol. 2024;13:10.","journal-title":"Exp Hematol Oncol"},{"key":"840_CR209","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity. Cell Metab. 2021;33:988\u2013e10001007.","journal-title":"Cell Metab"},{"key":"840_CR210","doi-asserted-by":"crossref","first-page":"2525403","DOI":"10.1080\/07853890.2025.2525403","volume":"57","author":"Y Heinrich-Sanchez","year":"2025","unstructured":"Heinrich-Sanchez Y, Vital M. Trimethylamine-N-oxide formation, the bacterial taxa involved and intervention strategies to reduce its concentration in the human body. Ann Med. 2025;57:2525403.","journal-title":"Ann Med"},{"key":"840_CR211","doi-asserted-by":"crossref","first-page":"118592","DOI":"10.1016\/j.biopha.2025.118592","volume":"192","author":"B Saha","year":"2025","unstructured":"Saha B, Banerjee A, Pathak R, Duttaroy AK, Pathak S. Trimethylamine N-Oxide (TMAO) and cancer risk: Insights into a possible link. Biomed Pharmacother. 2025;192:118592.","journal-title":"Biomed Pharmacother"},{"key":"840_CR212","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s13402-024-00920-2","volume":"47","author":"W Zhang","year":"2024","unstructured":"Zhang W, Qin X, Zhang K, Ma J, Li M, Jin G, Liu X, Wang S, Wang B, Wu J, et al. Microbial metabolite trimethylamine-N-oxide induces intestinal carcinogenesis through inhibiting farnesoid X receptor signaling. Cell Oncol (Dordr). 2024;47:1183\u201399.","journal-title":"Cell Oncol (Dordr)"},{"key":"840_CR213","doi-asserted-by":"crossref","first-page":"840236","DOI":"10.3389\/fmicb.2022.840236","volume":"13","author":"PM Tran","year":"2022","unstructured":"Tran PM, Tang SS, Salgado-Pabon W. Staphylococcus aureus beta-Toxin Exerts Anti-angiogenic Effects by Inhibiting Re-endothelialization and Neovessel Formation. Front Microbiol. 2022;13:840236.","journal-title":"Front Microbiol"},{"key":"840_CR214","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chom.2023.04.010","volume":"31","author":"SS Jiang","year":"2023","unstructured":"Jiang SS, Xie YL, Xiao XY, Kang ZR, Lin XL, Zhang L, Li CS, Qian Y, Xu PP, Leng XX, et al. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer. Cell Host Microbe. 2023;31:781\u2013e797789.","journal-title":"Cell Host Microbe"},{"key":"840_CR215","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1016\/j.cell.2025.06.018","volume":"188","author":"CM Phelps","year":"2025","unstructured":"Phelps CM, Willis NB, Duan T, Lee AH, Zhang Y, Rodriguez JD, Pandey SP, Laughlin CR, Rosen ABI, McPherson AC, et al. Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy. Cell. 2025;188:5680\u2013e57005628.","journal-title":"Cell"},{"key":"840_CR216","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13577-025-01304-w","volume":"38","author":"H Zhao","year":"2025","unstructured":"Zhao H, Yang F, Yang J, Yang S. Multifaceted roles of microbiota-derived deoxycholic acid in gastrointestinal cancers: from barrier disruption to therapeutic implications. Hum Cell. 2025;38:176.","journal-title":"Hum Cell"},{"key":"840_CR217","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/1538-7445.AM2025-2222","volume":"85","author":"M Nakazawa","year":"2025","unstructured":"Nakazawa M, Raj VL, Rajeshkumar N, Rastkari N, Davis M, De Oliveria E, Brancati M, Griffin E, Munjal K, Leatherman J, et al. Abstract 2222: Trimethylamine-N-oxide (TMAO) mediates immunotherapy resistance in advanced HCC. Cancer Res. 2025;85:2222\u20132222.","journal-title":"Cancer Res"},{"key":"840_CR218","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s40168-022-01408-7","volume":"10","author":"TL Montgomery","year":"2022","unstructured":"Montgomery TL, Eckstrom K, Lile KH, Caldwell S, Heney ER, Lahue KG, D\u2019Alessandro A, Wargo MJ, Krementsov DN. Lactobacillus reuteri tryptophan metabolism promotes host susceptibility to CNS autoimmunity. Microbiome. 2022;10:198.","journal-title":"Microbiome"},{"key":"840_CR219","first-page":"0102","volume":"6","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Li X, Qian F, Sun B, Wang X, Zhang Y, Zhang D, Geng M, Xie Z, Yang S. Fine-tuning Bacterial Cyclic di-AMP Production for Durable Antitumor Effects Through the Activation of the STING Pathway. Res (Wash D C). 2023;6:0102.","journal-title":"Res (Wash D C)"},{"key":"840_CR220","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.celrep.2015.04.031","volume":"11","author":"L Corrales","year":"2015","unstructured":"Corrales L, Glickman LH, McWhirter SM, Kanne DB, Sivick KE, Katibah GE, Woo SR, Lemmens E, Banda T, Leong JJ, et al. Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity. Cell Rep. 2015;11:1018\u201330.","journal-title":"Cell Rep"},{"issue":"6","key":"840_CR221","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/cells10061390","volume":"10","author":"S Aiello","year":"2021","unstructured":"Aiello S, Casiraghi F. Lysophosphatidic Acid: Promoter of Cancer Progression and of Tumor Microenvironment Development. A Promising Target for Anticancer Therapies? Cells. 2021;10(6):1390.","journal-title":"Cells"},{"issue":"17","key":"840_CR222","doi-asserted-by":"crossref","first-page":"e163128","DOI":"10.1172\/JCI163128","volume":"133","author":"JM Konen","year":"2023","unstructured":"Konen JM, Rodriguez BL, Wu H, Fradette JJ, Gibson L, Diao L, Wang J, Schmidt S, Wistuba II, Zhang J, Gibbons DL. Autotaxin suppresses cytotoxic T cells via LPAR5 to promote anti-PD-1 resistance in non-small cell lung cancer. J Clin Invest. 2023;133(17):e163128.","journal-title":"J Clin Invest"},{"key":"840_CR223","doi-asserted-by":"crossref","first-page":"110971","DOI":"10.1016\/j.isci.2024.110971","volume":"27","author":"MA Dacheux","year":"2024","unstructured":"Dacheux MA, Norman DD, Shin Y, Tigyi GJ, Lee SC. Deleting autotaxin in LysM+ myeloid cells impairs innate tumor immunity in models of metastatic melanoma. iScience. 2024;27:110971.","journal-title":"iScience"},{"key":"840_CR224","doi-asserted-by":"crossref","first-page":"531910","DOI":"10.3389\/fimmu.2020.531910","volume":"11","author":"D Mathew","year":"2020","unstructured":"Mathew D, Torres RM. Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1. Front Immunol. 2020;11:531910.","journal-title":"Front Immunol"},{"key":"840_CR225","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2021.08.003","volume":"161","author":"Y Cao","year":"2021","unstructured":"Cao Y, Wang Z, Yan Y, Ji L, He J, Xuan B, Shen C, Ma Y, Jiang S, Ma D, et al. Enterotoxigenic Bacteroidesfragilis Promotes Intestinal Inflammation and Malignancy by Inhibiting Exosome-Packaged miR-149-3p. Gastroenterology. 2021;161:1552\u2013e15661512.","journal-title":"Gastroenterology"},{"key":"840_CR226","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41417-024-00862-9","volume":"32","author":"Z Wu","year":"2025","unstructured":"Wu Z, Yu M, Zeng Y, Huang Y, Zheng W. LRP11-AS1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal Cancer via the miR-149-3p\/CDK4 pathway. Cancer Gene Ther. 2025;32:184\u201397.","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"840_CR227","doi-asserted-by":"crossref","first-page":"jjae179","DOI":"10.1093\/ecco-jcc\/jjae179","volume":"19","author":"Y Yan","year":"2025","unstructured":"Yan Y, Tian L, Zhao Y, Xuan B, Xu X, Ding J, Li W, Zhou YL, Zhang Y, Ma Y, et al. Bacteroides fragilis Toxin Suppresses METTL3-Mediated m6A Modification in Macrophage to Promote Inflammatory Bowel Disease. J Crohns Colitis. 2025;19(3):jjae179.","journal-title":"J Crohns Colitis"},{"key":"840_CR228","doi-asserted-by":"crossref","unstructured":"Chen Z, Guan D, Wang Z, Li X, Dong S, Huang J, Zhou W. Microbiota in cancer: molecular mechanisms and therapeutic interventions. MedComm (2020) 2023, 4:e417.","DOI":"10.1002\/mco2.417"},{"issue":"23","key":"840_CR229","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.3390\/cancers14235813","volume":"14","author":"S Fan","year":"2022","unstructured":"Fan S, Xing J, Jiang Z, Zhang Z, Zhang H, Wang D, Tang D. Effects of Long Non-Coding RNAs Induced by the Gut Microbiome on Regulating the Development of Colorectal Cancer. Cancers (Basel). 2022;14(23):5813.","journal-title":"Cancers (Basel)"},{"key":"840_CR230","doi-asserted-by":"crossref","first-page":"111127","DOI":"10.1016\/j.celrep.2022.111127","volume":"40","author":"X Lu","year":"2022","unstructured":"Lu X, Xu Q, Tong Y, Zhang Z, Dun G, Feng Y, Tang J, Han D, Mao Y, Deng L, et al. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis. Cell Rep. 2022;40:111127.","journal-title":"Cell Rep"},{"key":"840_CR231","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13099-025-00757-6","volume":"17","author":"Z Sadeghloo","year":"2025","unstructured":"Sadeghloo Z, Ebrahimi S, Hakemi-Vala M, Totonchi M, Sadeghi A, Fatemi N. Fusobacterium nucleatum and non-coding RNAs: orchestrating oncogenic pathways in colorectal cancer. Gut Pathog. 2025;17:78.","journal-title":"Gut Pathog"},{"key":"840_CR232","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12275-023-00100-1","volume":"62","author":"W Zeng","year":"2024","unstructured":"Zeng W, Pan J, Ye G. miR-135b Aggravates Fusobacterium nucleatum-Induced Cisplatin Resistance in Colorectal Cancer by Targeting KLF13. J Microbiol. 2024;62:63\u201373.","journal-title":"J Microbiol"},{"key":"840_CR233","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1219328","volume":"336","author":"T Olszak","year":"2012","unstructured":"Olszak T, An D, Zeissig S, Vera MP, Richter J, Franke A, Glickman JN, Siebert R, Baron RM, Kasper DL, Blumberg RS. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489\u201393.","journal-title":"Science"},{"key":"840_CR234","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1126\/science.aad9378","volume":"352","author":"T Gensollen","year":"2016","unstructured":"Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352:539\u201344.","journal-title":"Science"},{"key":"840_CR235","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1038\/s41467-024-48794-0","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Gao X, Liu Z, Shao F, Yu D, Zhao M, Qin X, Wang S. Microbiota regulates the TET1-mediated DNA hydroxymethylation program in innate lymphoid cell differentiation. Nat Commun. 2024;15:4792.","journal-title":"Nat Commun"},{"key":"840_CR236","doi-asserted-by":"crossref","first-page":"61917","DOI":"10.18632\/oncotarget.18716","volume":"8","author":"T Tahara","year":"2017","unstructured":"Tahara T, Hirata I, Nakano N, Tahara S, Horiguchi N, Kawamura T, Okubo M, Ishizuka T, Yamada H, Yoshida D, et al. Potential link between Fusobacterium enrichment and DNA methylation accumulation in the inflammatory colonic mucosa in ulcerative colitis. Oncotarget. 2017;8:61917\u201326.","journal-title":"Oncotarget"},{"key":"840_CR237","doi-asserted-by":"crossref","first-page":"24285","DOI":"10.1073\/pnas.1912129116","volume":"116","author":"I Sobhani","year":"2019","unstructured":"Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, de\u2019Angelis N, Rabot S, Canoui-Poitrine F, Mestivier D, et al. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci U S A. 2019;116:24285\u201395.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"840_CR238","doi-asserted-by":"crossref","first-page":"e000859","DOI":"10.1136\/bmjonc-2025-000859","volume":"4","author":"I Sobhani","year":"2025","unstructured":"Sobhani I, De Oliveiro Alves N, Charpy C, Bergsten E, Barau C, Vaysse A, Chamaillard M, Awaad S, Amiot A, Sadeghi M, et al. Colorectal cancer patient outcome is influenced by tumour-adherent bacteria through epigenetic regulation of cardinal genes including PHLPP1. BMJ Oncol. 2025;4:e000859.","journal-title":"BMJ Oncol"},{"key":"840_CR239","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13073-024-01344-1","volume":"16","author":"Z Liu","year":"2024","unstructured":"Liu Z, Zhang Q, Zhang H, Yi Z, Ma H, Wang X, Wang J, Liu Y, Zheng Y, Fang W, et al. Colorectal cancer microbiome programs DNA methylation of host cells by affecting methyl donor metabolism. Genome Med. 2024;16:77.","journal-title":"Genome Med"},{"key":"840_CR240","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ni.2886","volume":"15","author":"Y Obata","year":"2014","unstructured":"Obata Y, Furusawa Y, Endo TA, Sharif J, Takahashi D, Atarashi K, Nakayama M, Onawa S, Fujimura Y, Takahashi M, et al. The epigenetic regulator Uhrf1 facilitates the proliferation and maturation of colonic regulatory T cells. Nat Immunol. 2014;15:571\u20139.","journal-title":"Nat Immunol"},{"key":"840_CR241","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446\u201350.","journal-title":"Nature"},{"key":"840_CR242","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","volume":"33","author":"Y He","year":"2021","unstructured":"He Y, Fu L, Li Y, Wang W, Gong M, Zhang J, Dong X, Huang J, Wang Q, Mackay CR, et al. Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity. Cell Metab. 2021;33:988\u2013e10001007.","journal-title":"Cell Metab"},{"key":"840_CR243","doi-asserted-by":"crossref","first-page":"2508426","DOI":"10.1080\/19490976.2025.2508426","volume":"17","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Liu Y, Li Y, Bai G, Pang J, Wu M, Li J, Zhao X, Xia Y. Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases. Gut Microbes. 2025;17:2508426.","journal-title":"Gut Microbes"},{"key":"840_CR244","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.4110\/in.2024.24.e40","volume":"24","author":"Z Harmak","year":"2024","unstructured":"Harmak Z, Kone AS, Ghouzlani A, Ghazi B, Badou A. Beyond Tumor Borders: Intratumoral Microbiome Effects on Tumor Behavior and Therapeutic Responses. Immune Netw. 2024;24:e40.","journal-title":"Immune Netw"},{"key":"840_CR245","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s42003-024-06201-w","volume":"7","author":"B Udayasuryan","year":"2024","unstructured":"Udayasuryan B, Zhou Z, Ahmad RN, Sobol P, Deng C, Nguyen TTD, Kodikalla S, Morrison R, Goswami I, Slade DJ, et al. Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner. Commun Biol. 2024;7:551.","journal-title":"Commun Biol"},{"key":"840_CR246","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1158\/2767-9764.CRC-23-0367","volume":"4","author":"M Benej","year":"2024","unstructured":"Benej M, Hoyd R, Kreamer M, Wheeler CE, Grencewicz DJ, Choueiry F, Chan CHF, Zakharia Y, Ma Q, Dodd RD, et al. The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer. Cancer Res Commun. 2024;4:1690\u2013701.","journal-title":"Cancer Res Commun"},{"key":"840_CR247","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"41","author":"LE Colbert","year":"2023","unstructured":"Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, Harris TA, Elnaggar JH, Yoshida-Court K, Tomasic K, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41:1945\u201362. e1911.","journal-title":"Cancer Cell"},{"key":"840_CR248","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s11274-025-04716-w","volume":"41","author":"S Farmer","year":"2025","unstructured":"Farmer S, Francis O, Goyal N. Exploiting Salmonella typhimurium as a novel cancer therapeutic agent: from tumor colonization to metabolic engineering. World J Microbiol Biotechnol. 2025;41:482.","journal-title":"World J Microbiol Biotechnol"},{"issue":"23","key":"840_CR249","doi-asserted-by":"crossref","first-page":"e139900","DOI":"10.1172\/jci.insight.139900","volume":"6","author":"GM Mackie","year":"2021","unstructured":"Mackie GM, Copland A, Takahashi M, Nakanishi Y, Everard I, Kato T, Oda H, Kanaya T, Ohno H, Maslowski KM. Bacterial cancer therapy in autochthonous colorectal cancer affects tumor growth and metabolic landscape. JCI Insight. 2021;6(23):e139900.","journal-title":"JCI Insight"},{"key":"840_CR250","doi-asserted-by":"crossref","first-page":"101070","DOI":"10.1016\/j.xcrm.2023.101070","volume":"4","author":"S Zhou","year":"2023","unstructured":"Zhou S, Lin Y, Zhao Z, Lai Y, Lu M, Shao Z, Mo X, Mu Y, Liang Z, Wang X, et al. Targeted deprivation of methionine with engineered Salmonella leads to oncolysis and suppression of metastasis in broad types of animal tumor models. Cell Rep Med. 2023;4:101070.","journal-title":"Cell Rep Med"},{"issue":"8","key":"840_CR251","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/biom14080917","volume":"14","author":"X Bi","year":"2024","unstructured":"Bi X, Wang J, Liu C. Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer. Biomolecules. 2024;14(8):917.","journal-title":"Biomolecules"},{"key":"840_CR252","doi-asserted-by":"crossref","first-page":"1609889","DOI":"10.3389\/fonc.2025.1609889","volume":"15","author":"Y Tingting","year":"2025","unstructured":"Tingting Y, Xiaoling Z, Yu Z, Yan L, Yang L, Xueqin S, Shikai T. Interaction of intratumoral microbiota with the tumor immune microenvironment and its impact on cancer progression. Front Oncol. 2025;15:1609889.","journal-title":"Front Oncol"},{"key":"840_CR253","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1002\/mco2.376","volume":"4","author":"M Jiang","year":"2023","unstructured":"Jiang M, Yang Z, Dai J, Wu T, Jiao Z, Yu Y, Ning K, Chen W, Yang A. Intratumor microbiome: selective colonization in the tumor microenvironment and a vital regulator of tumor biology. MedComm (2020). 2023;4:e376.","journal-title":"MedComm (2020)"},{"key":"840_CR254","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity. 2015;42:344\u201355.","journal-title":"Immunity"},{"key":"840_CR255","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1038\/s41467-025-63451-w","volume":"16","author":"F Sch\u00f6pf","year":"2025","unstructured":"Sch\u00f6pf F, Marongiu GL, Milaj K, Sprink T, Kikhney J, Moter A, Roderer D. Structural basis of Fusobacterium nucleatum adhesin Fap2 interaction with receptors on cancer and immune cells. Nat Commun. 2025;16:8104.","journal-title":"Nat Commun"},{"key":"840_CR256","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00003086-199101000-00002","volume":"262","author":"WB Coley","year":"1991","unstructured":"Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893. Clin Orthop Relat Res. 1991;262:3\u201311.","journal-title":"Clin Orthop Relat Res"},{"issue":"15","key":"840_CR257","doi-asserted-by":"crossref","first-page":"e00206","DOI":"10.1128\/MCB.00206-19","volume":"39","author":"PJ Daschner","year":"2019","unstructured":"Daschner PJ, Rasooly A, White JD. Bugs as Cancer Drugs: Challenges and Opportunities. Mol Cell Biol. 2019;39(15):e00206\u201319.","journal-title":"Mol Cell Biol"},{"key":"840_CR258","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1097\/CM9.0000000000003807","volume":"138","author":"M Wang","year":"2025","unstructured":"Wang M, Liu M, Wang D, Yang D, Zeng Y, Lan Y, Wang Q. Engineered bacteria for cancer therapy: Advancements, challenges, and future directions. Chin Med J (Engl). 2025;138:3224\u201350.","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"840_CR259","doi-asserted-by":"crossref","first-page":"9726","DOI":"10.3390\/ijms24119726","volume":"24","author":"LN Ikryannikova","year":"2023","unstructured":"Ikryannikova LN, Gorokhovets NV, Belykh DA, Kurbatov LK, Zamyatnin AA Jr. Bacterial Therapy of Cancer: A Way to the Dustbin of History or to the Medicine of the Future? Int J Mol Sci. 2023;24(11):9726.","journal-title":"Int J Mol Sci"},{"key":"840_CR260","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1126\/science.1206843","volume":"333","author":"WC Ruder","year":"2011","unstructured":"Ruder WC, Lu T, Collins JJ. Synthetic biology moving into the clinic. Science. 2011;333:1248\u201352.","journal-title":"Science"},{"key":"840_CR261","doi-asserted-by":"crossref","first-page":"289ra284","DOI":"10.1126\/scitranslmed.aaa3519","volume":"7","author":"T Danino","year":"2015","unstructured":"Danino T, Prindle A, Kwong GA, Skalak M, Li H, Allen K, Hasty J, Bhatia SN. Programmable probiotics for detection of cancer in urine. Sci Transl Med. 2015;7:289ra284.","journal-title":"Sci Transl Med"},{"key":"840_CR262","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","volume":"25","author":"S Chowdhury","year":"2019","unstructured":"Chowdhury S, Castro S, Coker C, Hinchliffe TE, Arpaia N, Danino T. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25:1057\u201363.","journal-title":"Nat Med"},{"key":"840_CR263","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/1566523214666140305223912","volume":"14","author":"X Cheng","year":"2014","unstructured":"Cheng X, Zhang X, Cheng W, Chen J, Ma C, Yang B, Hua ZC. Tumor-specific delivery of histidine-rich glycoprotein suppresses tumor growth and metastasis by anti-angiogenesis and vessel normalization. Curr Gene Ther. 2014;14:75\u201385.","journal-title":"Curr Gene Ther"},{"key":"840_CR264","doi-asserted-by":"crossref","first-page":"eadt7298","DOI":"10.1126\/sciadv.adt7298","volume":"11","author":"XT Xie","year":"2025","unstructured":"Xie XT, Guan M, Cheng K, Li Y, Zhang B, Zhou YT, Tan LF, Dong PS, Chen S, Liu B, et al. Programmable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy. Sci Adv. 2025;11:eadt7298.","journal-title":"Sci Adv"},{"key":"840_CR265","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/s41467-023-37225-1","volume":"14","author":"X Ma","year":"2023","unstructured":"Ma X, Liang X, Li Y, Feng Q, Cheng K, Ma N, Zhu F, Guo X, Yue Y, Liu G, et al. Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field. Nat Commun. 2023;14:1606.","journal-title":"Nat Commun"},{"key":"840_CR266","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41551-021-00772-3","volume":"6","author":"T Chien","year":"2022","unstructured":"Chien T, Harimoto T, Kepecs B, Gray K, Coker C, Hou N, Pu K, Azad T, Nolasco A, Pavlicova M, Danino T. Enhancing the tropism of bacteria via genetically programmed biosensors. Nat Biomed Eng. 2022;6:94\u2013104.","journal-title":"Nat Biomed Eng"},{"key":"840_CR267","doi-asserted-by":"crossref","first-page":"e06486","DOI":"10.1002\/advs.202406486","volume":"12","author":"ZP Zou","year":"2025","unstructured":"Zou ZP, Wang XG, Shi XR, Sun ST, Mi J, Zhang XP, Yin BC, Zhou Y, Ye BC. Self-Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery. Adv Sci (Weinh). 2025;12:e06486.","journal-title":"Adv Sci (Weinh)"},{"key":"840_CR268","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature18930","volume":"536","author":"MO Din","year":"2016","unstructured":"Din MO, Danino T, Prindle A, Skalak M, Selimkhanov J, Allen K, Julio E, Atolia E, Tsimring LS, Bhatia SN, Hasty J. Synchronized cycles of bacterial lysis for in vivo delivery. Nature. 2016;536:81\u20135.","journal-title":"Nature"},{"key":"840_CR269","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/procel\/pwaf085","volume":"17","author":"L Niu","year":"2026","unstructured":"Niu L, Deng Z, Jin Y, Guan N, Ye H. Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives. Protein Cell. 2026;17:279\u2013303.","journal-title":"Protein Cell"},{"key":"840_CR270","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jbiotec.2015.07.010","volume":"211","author":"KM Broadway","year":"2015","unstructured":"Broadway KM, Denson EA, Jensen RV, Scharf BE. Rescuing chemotaxis of the anticancer agent Salmonella enterica serovar Typhimurium VNP20009. J Biotechnol. 2015;211:117\u201320.","journal-title":"J Biotechnol"},{"key":"840_CR271","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jbiotec.2017.04.006","volume":"251","author":"KM Broadway","year":"2017","unstructured":"Broadway KM, Suh S, Behkam B, Scharf BE. Optimizing the restored chemotactic behavior of anticancer agent Salmonella enterica serovar Typhimurium VNP20009. J Biotechnol. 2017;251:76\u201383.","journal-title":"J Biotechnol"},{"issue":"18","key":"840_CR272","doi-asserted-by":"crossref","first-page":"e01362","DOI":"10.1128\/AEM.01362-18","volume":"84","author":"C Roggo","year":"2018","unstructured":"Roggo C, Clerc EE, Hadadi N, Carraro N, Stocker R, van der Meer JR. Heterologous Expression of Pseudomonas putida Methyl-Accepting Chemotaxis Proteins Yields Escherichia coli Cells Chemotactic to Aromatic Compounds. Appl Environ Microbiol. 2018;84(18):e01362\u201318.","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"840_CR273","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.3390\/ijms26115186","volume":"26","author":"KA Giang","year":"2025","unstructured":"Giang KA, Nilvebrant J, Liu H, K\u00e1rad\u00f3ttir H, Diao Y, Svensson Gelius S, Nygren P. An Anti-BCMA Affibody Affinity Protein for Therapeutic and Diagnostic Use in Multiple Myeloma. Int J Mol Sci. 2025;26(11):5186.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"840_CR274","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/biom13071042","volume":"13","author":"J Narbona","year":"2023","unstructured":"Narbona J, Hern\u00e1ndez-Baraza L, Gordo RG, Sanz L, Lacadena J. Nanobody-Based EGFR-Targeting Immunotoxins for Colorectal Cancer Treatment. Biomolecules. 2023;13(7):1042.","journal-title":"Biomolecules"},{"key":"840_CR275","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12953-022-00190-6","volume":"20","author":"T Lamtha","year":"2022","unstructured":"Lamtha T, Krobthong S, Yingchutrakul Y, Samutrtai P, Gerner C, Tabtimmai L, Choowongkomon K. A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approach. Proteome Sci. 2022;20:9.","journal-title":"Proteome Sci"},{"key":"840_CR276","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nbt.2023.09.002","volume":"77","author":"KA Giang","year":"2023","unstructured":"Giang KA, Boxaspen T, Diao Y, Nilvebrant J, Kosugi-Kanaya M, Kanaya M, Krokeide SZ, Lehmann F, Svensson Gelius S, Malmberg KJ, Nygren P. Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells. N Biotechnol. 2023;77:139\u201348.","journal-title":"N Biotechnol"},{"key":"840_CR277","doi-asserted-by":"crossref","first-page":"e70033","DOI":"10.1111\/1751-7915.70033","volume":"17","author":"C Dahlsson Leitao","year":"2024","unstructured":"Dahlsson Leitao C, St\u00e5hl S, L\u00f6fblom J. Surface-engineered bacteria in drug development. Microb Biotechnol. 2024;17:e70033.","journal-title":"Microb Biotechnol"},{"key":"840_CR278","first-page":"100030","volume":"13","author":"LY Wu","year":"2026","unstructured":"Wu LY, Qiu JH, Qiao XY, Li L, Qiao LY, Li CY, Sun Y, Zhang SH, Du ZZ, Chang XY, et al. Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity. Mil Med Res. 2026;13:100030.","journal-title":"Mil Med Res"},{"key":"840_CR279","doi-asserted-by":"crossref","unstructured":"Wang Z, Fang C, Zhou X, Yang S, Shah YM, Romee R, Moon JJ, Li J. Engineering tumor-homing bacteria as membrane-anchored immune checkpoint-blockade interfaces. bioRxiv 2026:2026.06.10.731477.","DOI":"10.64898\/2026.06.10.731477"},{"key":"840_CR280","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.vaccine.2007.03.008","volume":"25","author":"M Bereta","year":"2007","unstructured":"Bereta M, Hayhurst A, Gajda M, Chorobik P, Targosz M, Marcinkiewicz J, Kaufman HL. Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies. Vaccine. 2007;25:4183\u201392.","journal-title":"Vaccine"},{"key":"840_CR281","doi-asserted-by":"crossref","first-page":"214552","DOI":"10.1016\/j.bioadv.2025.214552","volume":"180","author":"Z Li","year":"2026","unstructured":"Li Z, Liang D, Huo M, Guan L, Liu Z, Gu F, Guan X, Chen L. PD-L1 nanobody-engineered bacterial outer membrane vesicles delivering cuproptosis micelles for potentiated cancer immunotherapy. Biomater Adv. 2026;180:214552.","journal-title":"Biomater Adv"},{"key":"840_CR282","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/MS9.0000000000004400","volume":"88","author":"MS Mehmood","year":"2026","unstructured":"Mehmood MS, Abid M, Hajj F. Engineered Lactobacillus expressing tumor-killing cytokines: a novel biotherapeutic. Ann Med Surg (Lond). 2026;88:1040\u20131.","journal-title":"Ann Med Surg (Lond)"},{"key":"840_CR283","doi-asserted-by":"crossref","first-page":"e09604","DOI":"10.1002\/advs.202509604","volume":"12","author":"C Chen","year":"2025","unstructured":"Chen C, Zhu J, Liu X, Shao J, Chen A, Mei Y, Zhang X, Chen Q, Li L, Liu B. Intravenous iRGD-Guided, RBC-Membrane Camouflaged Lactococcus Lactis Remodels Cold NSCLC and Enhances PD-1 Blockade. Adv Sci (Weinh). 2025;12:e09604.","journal-title":"Adv Sci (Weinh)"},{"key":"840_CR284","doi-asserted-by":"crossref","first-page":"139537","DOI":"10.1016\/j.ijbiomac.2025.139537","volume":"295","author":"X Li","year":"2025","unstructured":"Li X, Wang Y, Wang Y, Xie H, Gong R, Wu X, Chen J, Sun C, Gu Y. Anti-tumor activity of an \u03b1PD-L1-PE38 immunotoxin delivered by engineered Nissle 1917. Int J Biol Macromol. 2025;295:139537.","journal-title":"Int J Biol Macromol"},{"key":"840_CR285","doi-asserted-by":"crossref","first-page":"147361","DOI":"10.1016\/j.ijbiomac.2025.147361","volume":"327","author":"S He","year":"2025","unstructured":"He S, Zhao S, Luo X, Liu N, Zhang Y, Wang S, Yang Y, Ma L, Zhang C. Intelligent bacterial platform induces programmed death-ligand 1 lysosomal degradation to enhance antitumor immunity. Int J Biol Macromol. 2025;327:147361.","journal-title":"Int J Biol Macromol"},{"key":"840_CR286","first-page":"20240183","volume":"5","author":"W Huang","year":"2025","unstructured":"Huang W, Cao G, Tan M, Jia F, Zhang J, Su W, Yin Y, Wang H. Personalized Cancer Immunotherapy Boosted by cGAS-STING-Targeted Nanovaccines in Combination With Nutrient Modulation. Explor (Beijing). 2025;5:20240183.","journal-title":"Explor (Beijing)"},{"key":"840_CR287","doi-asserted-by":"crossref","first-page":"e18172","DOI":"10.1002\/advs.202518172","volume":"13","author":"PS Dong","year":"2026","unstructured":"Dong PS, Yao T, Li Y, Yan ZH, Xie XT, Zou JH, Cheng K, Fan JX, Zhao YD, Xu QR. Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy. Adv Sci (Weinh). 2026;13:e18172.","journal-title":"Adv Sci (Weinh)"},{"key":"840_CR288","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2025.03.003","volume":"112","author":"H Wang","year":"2025","unstructured":"Wang H, Xu F, Wang C. Metabolic reprogramming of tumor microenviroment by engineered bacteria. Semin Cancer Biol. 2025;112:58\u201370.","journal-title":"Semin Cancer Biol"},{"key":"840_CR289","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s11427-025-3185-y","volume":"69","author":"G Kang","year":"2026","unstructured":"Kang G, Zhang B, Wu J, Wang L, Huang H. Engineering probiotics as living biotherapeutics: a novel paradigm of restoring physiological barriers via targeted short-chain fatty acid delivery. Sci China Life Sci. 2026;69:1789\u201392.","journal-title":"Sci China Life Sci"},{"key":"840_CR290","doi-asserted-by":"crossref","first-page":"100515","DOI":"10.1016\/j.mtbio.2022.100515","volume":"18","author":"P Ji","year":"2023","unstructured":"Ji P, An B, Jie Z, Wang L, Qiu S, Ge C, Wu Q, Shi J, Huo M. Genetically engineered probiotics as catalytic glucose depriver for tumor starvation therapy. Mater Today Bio. 2023;18:100515.","journal-title":"Mater Today Bio"},{"key":"840_CR291","doi-asserted-by":"crossref","first-page":"114781","DOI":"10.1016\/j.jconrel.2026.114781","volume":"393","author":"P Mao","year":"2026","unstructured":"Mao P, Wang X, Peng Y, de S\u00e1 Alves M, Almeida JD, Liu Y, Zhou S, Zhao Z, Su L, Wang X, et al. Genetically engineered Salmonella, SGN1, as a tumor microenvironment-targeting modality capable of methionine reduction for oral squamous cell carcinoma. J Control Release. 2026;393:114781.","journal-title":"J Control Release"},{"key":"840_CR292","doi-asserted-by":"crossref","first-page":"24555","DOI":"10.1021\/jacs.5c05148","volume":"147","author":"QR Li","year":"2025","unstructured":"Li QR, Zhang X, Zhang C, Zhang Y, Niu MT, Chen Z, Zhang SM, He J, Chen WH, Zhang XZ. Biomineralized Engineered Bacterial Outer Membrane Vesicles as cGAS-STING Nanoagonists Synergize with Lactate Metabolism Modulation to Potentiate Immunotherapy. J Am Chem Soc. 2025;147:24555\u201372.","journal-title":"J Am Chem Soc"},{"key":"840_CR293","doi-asserted-by":"crossref","first-page":"114738","DOI":"10.1016\/j.jconrel.2026.114738","volume":"392","author":"X Li","year":"2026","unstructured":"Li X, Wang Y, Xie H, Sun C, Chen J, Zhang B, Wang W, Gu Y. Engineering Escherichia coli Nissle 1917 to scavenge lactate enhances anti-tumor immunity. J Control Release. 2026;392:114738.","journal-title":"J Control Release"},{"key":"840_CR294","doi-asserted-by":"crossref","first-page":"e24303","DOI":"10.1002\/advs.202524303","volume":"13","author":"F Peng","year":"2026","unstructured":"Peng F, Lei Z, Zhang Z, Su Z, Zhang C, Yang H, Liu S, Hu M, Wang Y, Guo L, et al. Engineered Bacteria-Vesicle Delivered Lactate Reprogramming Boosts Tumor Radiosensitivity. Adv Sci (Weinh). 2026;13:e24303.","journal-title":"Adv Sci (Weinh)"},{"key":"840_CR295","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, Sherry RM, Topalian SL, Yang JC, Stock F, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002;20:142\u201352.","journal-title":"J Clin Oncol"},{"key":"840_CR296","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1158\/1078-0432.CCR-24-3952","volume":"31","author":"BE Nelson","year":"2025","unstructured":"Nelson BE, Janku F, Fu S, Dumbrava EE, Hong DS, Karp DD, Naing A, Rodon J, Tsimberidou AM, Murthy R, et al. Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors. Clin Cancer Res. 2025;31:3864\u201375.","journal-title":"Clin Cancer Res"},{"key":"840_CR297","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/s41467-024-44776-4","volume":"15","author":"CR Gurbatri","year":"2024","unstructured":"Gurbatri CR, Radford GA, Vrbanac L, Im J, Thomas EM, Coker C, Taylor SR, Jang Y, Sivan A, Rhee K, et al. Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nat Commun. 2024;15:646.","journal-title":"Nat Commun"},{"key":"840_CR298","doi-asserted-by":"crossref","first-page":"721","DOI":"10.18632\/oncotarget.28769","volume":"16","author":"KR Cron","year":"2025","unstructured":"Cron KR, Fang P, Pham O, Janes J, Brandenburg J, Lu W, Zhu J, Peterson B, Tribble S, Kehoe H, et al. ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15\/IL-15R\u03b1 and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response. Oncotarget. 2025;16:721\u201340.","journal-title":"Oncotarget"},{"key":"840_CR299","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, Pei S, Lu W, Li Y, Huang JD, Xiao Y, Liu C. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188:1842\u2013e18571820.","journal-title":"Cell"},{"key":"840_CR300","doi-asserted-by":"crossref","first-page":"113863","DOI":"10.1016\/j.isci.2025.113863","volume":"28","author":"C Han","year":"2025","unstructured":"Han C, Li J, Qiao X, Wang M, Yang L, Zhang X, Bao F, Qiao L, Jin Y, Li C, et al. A stable and antibiotic-free plasmid expression system for Salmonella typhimurium VNP20009 in tumor therapy. iScience. 2025;28:113863.","journal-title":"iScience"},{"key":"840_CR301","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1038\/s41467-024-50639-9","volume":"15","author":"N Radde","year":"2024","unstructured":"Radde N, Mortensen GA, Bhat D, Shah S, Clements JJ, Leonard SP, McGuffie MJ, Mishler DM, Barrick JE. Measuring the burden of hundreds of BioBricks defines an evolutionary limit on constructability in synthetic biology. Nat Commun. 2024;15:6242.","journal-title":"Nat Commun"},{"key":"840_CR302","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1021\/sb3000639","volume":"1","author":"T Danino","year":"2012","unstructured":"Danino T, Lo J, Prindle A, Hasty J, Bhatia SN. In Vivo Gene Expression Dynamics of Tumor-Targeted Bacteria. ACS Synth Biol. 2012;1:465\u201370.","journal-title":"ACS Synth Biol"},{"key":"840_CR303","doi-asserted-by":"crossref","first-page":"104088","DOI":"10.1016\/j.critrevonc.2023.104088","volume":"190","author":"A Arboleda-Garc\u00eda","year":"2023","unstructured":"Arboleda-Garc\u00eda A, Alarcon-Ruiz I, Boada-Acosta L, Boada Y, Vignoni A, Jantus-Lewintre E. Advancements in synthetic biology-based bacterial cancer therapy: A modular design approach. Crit Rev Oncol Hematol. 2023;190:104088.","journal-title":"Crit Rev Oncol Hematol"},{"key":"840_CR304","doi-asserted-by":"crossref","first-page":"0049","DOI":"10.34133\/bdr.0049","volume":"6","author":"F Liguori","year":"2024","unstructured":"Liguori F, Pellicciotta N, Milanetti E, Xi Windemuth S, Ruocco G, Di Leonardo R, Danino T. Dynamic Gene Expression Mitigates Mutational Escape in Lysis-Driven Bacteria Cancer Therapy. Biodes Res. 2024;6:0049.","journal-title":"Biodes Res"},{"issue":"5","key":"840_CR305","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3390\/biomedicines13051261","volume":"13","author":"Q Tan","year":"2025","unstructured":"Tan Q, Cao X, Zou F, Wang H, Xiong L, Deng S. Spatial Heterogeneity of Intratumoral Microbiota: A New Frontier in Cancer Immunotherapy Resistance. Biomedicines. 2025;13(5):1261.","journal-title":"Biomedicines"},{"key":"840_CR306","doi-asserted-by":"crossref","first-page":"e1382791","DOI":"10.1080\/2162402X.2017.1382791","volume":"7","author":"S Felgner","year":"2018","unstructured":"Felgner S, Kocijancic D, Frahm M, Heise U, Rohde M, Zimmermann K, Falk C, Erhardt M, Weiss S. Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy. Oncoimmunology. 2018;7:e1382791.","journal-title":"Oncoimmunology"},{"key":"840_CR307","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1128\/IAI.01274-08","volume":"77","author":"ML Leong","year":"2009","unstructured":"Leong ML, Hampl J, Liu W, Mathur S, Bahjat KS, Luckett W, Dubensky TW Jr., Brockstedt DG. Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice. Infect Immun. 2009;77:3958\u201368.","journal-title":"Infect Immun"},{"key":"840_CR308","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/acssynbio.5c00598","volume":"15","author":"J Hahn","year":"2026","unstructured":"Hahn J, Harimoto T, Chen YY, Liguori F, Leong KW, Danino T. Design and Modeling of Biosensor-Driven Encapsulation Systems for Systemic Delivery of Bacterial Cancer Therapy. ACS Synth Biol. 2026;15:481\u20139.","journal-title":"ACS Synth Biol"},{"issue":"1","key":"840_CR309","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-026-01827-1","volume":"19","author":"L Qiao","year":"2026","unstructured":"Qiao L, Wu L, Xiao Y, Qiu J, Qiao X, Dong X, Lei C, Wang W, Zhao Y, Hua Z. From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine. J Hematol Oncol. 2026;19(1):74.","journal-title":"J Hematol Oncol"},{"key":"840_CR310","doi-asserted-by":"crossref","first-page":"e17730","DOI":"10.1002\/advs.202517730","volume":"13","author":"Y Liu","year":"2026","unstructured":"Liu Y, Yao J, Deng J, Zhou M, Shen K, Sun S, Gao X, Zhang Q, Xu H. Attenuated Bacteria-Based Tumor Therapy: Clinical Application Risks, Marketing Approval Restrictions, and Coping Strategies. Adv Sci (Weinh). 2026;13:e17730.","journal-title":"Adv Sci (Weinh)"},{"key":"840_CR311","doi-asserted-by":"crossref","first-page":"1441290","DOI":"10.3389\/frmbi.2024.1441290","volume":"3","author":"D Barberio","year":"2024","unstructured":"Barberio D. Navigating regulatory and analytical challenges in live biotherapeutic product development and manufacturing. Front Microbiomes. 2024;3:1441290.","journal-title":"Front Microbiomes"},{"key":"840_CR312","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ymthe.2025.11.013","volume":"34","author":"X Xiang","year":"2026","unstructured":"Xiang X, Zhou Z, Rao X, Jiang XR. Recent advances of engineered bacteria for therapeutic applications. Mol Ther. 2026;34:714\u201333.","journal-title":"Mol Ther"},{"key":"840_CR313","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coisb.2017.05.009","volume":"5","author":"T Chien","year":"2017","unstructured":"Chien T, Doshi A, Danino T. Advances in bacterial cancer therapies using synthetic biology. Curr Opin Syst Biol. 2017;5:1\u20138.","journal-title":"Curr Opin Syst Biol"},{"key":"840_CR314","doi-asserted-by":"crossref","first-page":"e1761","DOI":"10.1002\/wnan.1761","volume":"14","author":"W Sato","year":"2022","unstructured":"Sato W, Zajkowski T, Moser F, Adamala KP. Synthetic cells in biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022;14:e1761.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"840_CR315","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41564-026-02279-6","volume":"11","author":"H Zhou","year":"2026","unstructured":"Zhou H, Sun R, Nie X, Xia L, Dong H, Liu Y, Hou S, Dong W, Zhu X, Yao Y, et al. A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice. Nat Microbiol. 2026;11:993\u20131007.","journal-title":"Nat Microbiol"},{"key":"840_CR316","doi-asserted-by":"crossref","first-page":"e07820","DOI":"10.1002\/advs.202507820","volume":"12","author":"J Chen","year":"2025","unstructured":"Chen J, Chen J, Chen Y, Yuan W, Zhang J, Wang G, Dai Z. Engineering Bacteria as Living Therapeutics in Cancer Therapy. Adv Sci (Weinh). 2025;12:e07820.","journal-title":"Adv Sci (Weinh)"},{"key":"840_CR317","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12916-025-04183-y","volume":"23","author":"A Lin","year":"2025","unstructured":"Lin A, Huang L, Jiang A, Zhu L, Mou W, Li Y, Zhang C, Liu Z, Zhang J, Cheng Q, et al. Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors. BMC Med. 2025;23:341.","journal-title":"BMC Med"},{"key":"840_CR318","doi-asserted-by":"crossref","first-page":"115701","DOI":"10.1016\/j.addr.2025.115701","volume":"227","author":"S Yang","year":"2025","unstructured":"Yang S, Yang M, Jennings M, Timek H, Haley AE, Romee R, Li J. Repurposing the bacterial surface display technology for drug delivery. Adv Drug Deliv Rev. 2025;227:115701.","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00840-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-026-00840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:57:11Z","timestamp":1792166231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-026-00840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":318,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1186\/s40164-026-00840-x","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"105"}}